{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":1198,"total_is_capped":false,"direct_labels_cover":2,"predictions_cover":1198,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"69c27d41982e","filters":{"topic":"Adenosine and Purinergic Signaling"}},"results":[{"id":"W1971084572","doi":"10.1038/nature09413","title":"Pannexin 1 channels mediate ‘find-me’ signal release and membrane permeability during apoptosis","year":2010,"lang":"en","type":"article","venue":"Nature","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1097,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"National Institute of Neurological Disorders and Stroke; National Institute of Allergy and Infectious Diseases; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute","keywords":"Pannexin; Cell biology; Apoptosis; Caspase; Biology; Effector; Programmed cell death; Biochemistry; Intracellular; Gap junction; Connexin","retraction":null,"screen_n_in":null,"score":{"opus":0.003986411262510915,"gpt":0.2265952639315254,"spread":0.2226088526690145,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018934,0.0001776964,0.0001477723,0.00003709187,0.0001212873,0.000028893,0.0001546126,0.001145922,0.0001527395],"category_scores_gemma":[0.000161963,0.0001570246,0.00007397909,0.00007794942,0.00008425723,0.000006440047,0.00010993,0.001229002,0.000005194408],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000004370437,"about_ca_system_score_gemma":0.00003643141,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000009369248,"about_ca_topic_score_gemma":0.00000349276,"domain_scores_codex":[0.9989948,0.00003950763,0.0001485682,0.0004093641,0.0001488265,0.0002589731],"domain_scores_gemma":[0.9994212,0.00002198715,0.00005553621,0.0002778127,0.00007945958,0.0001440496],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00009041234,0.00003452945,0.001337524,0.00004356628,0.00002748617,0.000004483888,0.00006444814,0.00002291362,0.9965777,0.00003989802,0.00143112,0.0003258543],"study_design_scores_gemma":[0.0005935568,0.00006867205,0.002675699,0.00001085173,0.00002393771,0.00003520828,0.00005080467,0.0001116461,0.9891702,0.0000820933,0.006933018,0.0002443235],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968496,0.001706562,0.0000165499,0.0005962818,0.0003346397,0.0001173242,0.000022387,0.0000221521,0.0003345334],"genre_scores_gemma":[0.9973143,0.0001280489,0.0002285139,0.0003834852,0.001214153,0.00001330772,0.00006756706,0.00002274518,0.0006278568],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007407574,"threshold_uncertainty_score":0.8838397,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2095988220","doi":"10.1007/s11302-006-9003-5","title":"The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance","year":2006,"lang":"en","type":"article","venue":"Purinergic Signalling","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":927,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval","funders":"National Heart, Lung, and Blood Institute; National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; National Institutes of Health; Deutsche Forschungsgemeinschaft","keywords":"Biology; Extracellular; Apyrase; Immune system; Purinergic receptor; Nucleoside triphosphate; Receptor; Immunology; Transplantation; Cell biology; Nucleotide; Genetics; Medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.009584253452762965,"gpt":0.2036629346349473,"spread":0.1940786811821843,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002190296,0.000166404,0.0001456066,0.00003020423,0.0003038932,0.00003128795,0.0001366802,0.0001279562,0.00001144829],"category_scores_gemma":[0.00007484745,0.0001170569,0.00007343588,0.000126134,0.0001401352,0.000006686503,0.00006536928,0.0001648055,0.000001341908],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000006254866,"about_ca_system_score_gemma":0.00003199256,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004768323,"about_ca_topic_score_gemma":0.000006885369,"domain_scores_codex":[0.9988984,0.0001198314,0.0003108404,0.0003104696,0.0001442317,0.0002161756],"domain_scores_gemma":[0.999372,0.00012745,0.0001560277,0.0002021241,0.00009524111,0.00004713318],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001399262,0.00002753161,0.002738839,0.00001740914,0.00002775939,0.000003270713,0.00001168003,0.01130909,0.9818329,0.001960527,0.001534584,0.0003965379],"study_design_scores_gemma":[0.00344895,0.001851901,0.185801,0.0001734449,0.0003352978,0.00007893369,0.001154655,0.007659713,0.7199818,0.03553984,0.04217055,0.001803892],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.986077,0.00834011,0.004892007,0.00005849815,0.00008428231,0.0001409264,0.00001486549,0.00001806703,0.0003742976],"genre_scores_gemma":[0.9983853,0.0001966929,0.0004854808,0.00005337721,0.0004662793,0.0000135118,0.00007863489,0.00001782913,0.00030287],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.261851,"threshold_uncertainty_score":0.477344,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2591655768","doi":"10.1111/imr.12528","title":"The ectonucleotidases <scp>CD</scp>39 and <scp>CD</scp>73: Novel checkpoint inhibitor targets","year":2017,"lang":"en","type":"review","venue":"Immunological Reviews","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":895,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"National Institute of Allergy and Infectious Diseases; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Terry Fox Research Institute; Leona M. and Harry B. Helmsley Charitable Trust; Canadian Institutes of Health Research; Leukemia and Lymphoma Society of Canada; National Cancer Institute; National Institutes of Health","keywords":"Immune system; Adenosinergic; Immunology; Cancer; Purinergic receptor; Immune checkpoint; Cancer research; Cancer immunotherapy; Biology; Immunotherapy; Extracellular; Cell biology; Receptor; Adenosine receptor","retraction":null,"screen_n_in":null,"score":{"opus":0.07840933402749782,"gpt":0.3386039492601004,"spread":0.2601946152326026,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001523624,0.001192189,0.002793056,0.00008416318,0.000866535,0.0003489179,0.001609936,0.001228178,0.00002096013],"category_scores_gemma":[0.009653599,0.0006744066,0.001512236,0.0001868754,0.0007916905,0.00001801386,0.001360533,0.001046788,0.000255022],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005407403,"about_ca_system_score_gemma":0.0002357635,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001637322,"about_ca_topic_score_gemma":0.000004513939,"domain_scores_codex":[0.9950502,0.0006202605,0.001685309,0.001328992,0.0002975035,0.001017723],"domain_scores_gemma":[0.9952046,0.0008349965,0.001733206,0.001828234,0.0001540791,0.0002449357],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000004872052,0.0001883686,0.000006675181,0.003070194,0.0005167857,0.00004658319,0.00003028134,3.230049e-7,0.004787583,0.0002066316,0.02631883,0.9648229],"study_design_scores_gemma":[0.0003231513,0.0003498646,0.00004836542,0.0040909,0.0005045069,0.0001788161,0.00003601837,8.047209e-7,0.0005773251,0.00004428774,0.993623,0.0002229724],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004354931,0.9943354,0.00009314113,0.00004751292,0.000564752,0.001652903,0.000084397,0.00004982618,0.002736552],"genre_scores_gemma":[0.0001153717,0.9909717,0.000471238,0.0001635208,0.001208072,0.0004751233,0.0003278194,0.0001041254,0.006162985],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9673042,"threshold_uncertainty_score":0.9995707,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1975921630","doi":"10.1007/s00424-003-1103-2","title":"The equilibrative nucleoside transporter family, SLC29","year":2004,"lang":"en","type":"review","venue":"Pflügers Archiv - European Journal of Physiology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":707,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Nucleoside transporter; Nucleoside; Biology; Biochemistry; Transporter; Transmembrane domain; Adenosine; Nucleotide; Cell biology; Receptor; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.02498948043081772,"gpt":0.2795954239196346,"spread":0.2546059434888169,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005881008,0.0004710811,0.00101513,0.00009992253,0.0001793296,0.00003683523,0.001059117,0.0001067628,0.00002026426],"category_scores_gemma":[0.00005397722,0.0002828962,0.001073346,0.0001119499,0.000357667,0.000007709578,0.0001690195,0.0007069513,0.00004004309],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002087957,"about_ca_system_score_gemma":0.0004072179,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001660672,"about_ca_topic_score_gemma":3.135279e-7,"domain_scores_codex":[0.9967536,0.001165953,0.001093731,0.0003768909,0.0001716775,0.0004381789],"domain_scores_gemma":[0.9980621,0.0001280717,0.001096989,0.0004597374,0.00009106258,0.0001619794],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005797322,0.0003056444,0.000002641905,0.004550945,0.004007014,0.000892465,0.0007355653,0.0004396339,0.08888383,0.000721298,0.04345256,0.8554287],"study_design_scores_gemma":[0.0004246729,0.0006475243,0.00004326378,0.001803272,0.0003607449,0.0002771568,0.00005792014,7.695914e-7,0.0001554394,0.0002341299,0.99567,0.0003251295],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001110916,0.9950707,0.0006610214,0.00006223915,0.0004494167,0.0001866376,0.00002836206,0.000006894576,0.002423819],"genre_scores_gemma":[0.002410264,0.9948274,0.0004089091,0.0001603388,0.001754653,0.000003077844,0.0000808619,0.000116335,0.0002381745],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9522174,"threshold_uncertainty_score":0.9999623,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2062761137","doi":"10.1073/pnas.0908801107","title":"Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis","year":2010,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":567,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Adenosine; Cancer research; Metastasis; Immune system; Primary tumor; Chemotaxis; Acquired immune system; Monoclonal antibody therapy; Immunotherapy; Antibody; In vivo; Biology; Cancer; Immunology; Medicine; Receptor; Internal medicine; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.01867592705942324,"gpt":0.2942254017963266,"spread":0.2755494747369033,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004874887,0.00007530076,0.0000966031,0.00005852624,0.0001176091,0.00001755377,0.0003292896,0.00005634776,0.000006801815],"category_scores_gemma":[0.0001385289,0.00004787248,0.00004499881,0.0002339061,0.0005081335,0.00002203901,0.0001068719,0.00009975704,1.857568e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000001012233,"about_ca_system_score_gemma":0.0000217192,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005405021,"about_ca_topic_score_gemma":1.868067e-8,"domain_scores_codex":[0.9991981,0.000003487134,0.0001544855,0.0001913318,0.0003526395,0.00009999881],"domain_scores_gemma":[0.9996041,0.00001619841,0.0001823515,0.000006643471,0.0001632142,0.00002746657],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000009343472,0.0000217483,0.01846861,0.00001296588,0.00001277814,3.365565e-9,0.0000179277,0.000002020842,0.9766675,0.004306342,0.0003732596,0.0001075335],"study_design_scores_gemma":[0.0001520836,0.00003772954,0.05287581,0.00001277097,0.000005454626,0.00005281474,0.00003240707,0.00002691986,0.944147,0.002318548,0.000277068,0.0000613857],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971967,0.0004303124,9.959656e-7,0.001182298,0.0000137647,0.00006900194,0.00001579009,0.000002814891,0.001088376],"genre_scores_gemma":[0.9987713,0.000111535,0.0006740888,0.0002782049,0.0001338748,0.000002239075,4.576569e-7,0.000003548478,0.00002481785],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0344072,"threshold_uncertainty_score":0.1952183,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3033331291","doi":"10.1038/s41571-020-0382-2","title":"The adenosine pathway in immuno-oncology","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":565,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Adenosinergic; Immunotherapy; Immune system; Cancer; Cancer research; Medicine; Cancer immunotherapy; Immunology; Biology; Adenosine receptor; Internal medicine; Receptor","retraction":null,"screen_n_in":null,"score":{"opus":0.09757574864050292,"gpt":0.4791573120742012,"spread":0.3815815634336983,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.004761691,0.0007747429,0.005229671,0.00008304344,0.0001487764,0.00003160646,0.001566584,0.005924967,0.00005493251],"category_scores_gemma":[0.006134814,0.0004559152,0.002059686,0.0005584477,0.0003752485,0.000004415027,0.00073057,0.004830753,0.000272754],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002062766,"about_ca_system_score_gemma":0.002638046,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000455015,"about_ca_topic_score_gemma":0.00005406389,"domain_scores_codex":[0.9892745,0.004702638,0.003871138,0.001249883,0.0002093858,0.0006924328],"domain_scores_gemma":[0.9944251,0.002126833,0.001957383,0.001094737,0.0001167986,0.0002791311],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007065667,0.0001695595,0.000005541053,0.001045442,0.0001796534,0.0001484806,0.000005512852,1.45236e-7,0.000005267728,0.000174961,0.1086387,0.8895561],"study_design_scores_gemma":[0.0006605844,0.001504558,0.000002538777,0.001826974,0.0003547254,0.0002013819,0.000007251877,8.906737e-7,0.00000322778,0.00003965985,0.9949271,0.0004710839],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000002732294,0.9906471,0.00002186631,0.001560087,0.002235936,0.001761651,0.00002494775,0.00001868722,0.00372702],"genre_scores_gemma":[0.000008199268,0.9903402,0.0004609791,0.002757831,0.00460371,0.000406075,0.000402302,0.00009537934,0.0009252877],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.889085,"threshold_uncertainty_score":0.9997892,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2066502054","doi":"10.1038/onc.2010.292","title":"Extracellular adenosine triphosphate and adenosine in cancer","year":2010,"lang":"en","type":"review","venue":"Oncogene","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":564,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Extracellular; Adenosine; Biology; Purinergic signalling; Cell biology; Adenosine triphosphate; Adenosine receptor; Adenosine A3 receptor; Biochemistry; Receptor; Agonist","retraction":null,"screen_n_in":null,"score":{"opus":0.03306739544596465,"gpt":0.3405496208796491,"spread":0.3074822254336844,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002321711,0.0005049445,0.001023964,0.0001344958,0.00005823267,0.00003558584,0.0002973007,0.0008254505,0.0001914584],"category_scores_gemma":[0.00004492913,0.0004399673,0.0002263897,0.0002368718,0.0000827433,0.00000414943,0.0001861145,0.0004789766,0.00001659823],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003072008,"about_ca_system_score_gemma":0.0003020002,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000961363,"about_ca_topic_score_gemma":0.00004934783,"domain_scores_codex":[0.9980747,0.00008711054,0.000573212,0.0007137745,0.0001494085,0.000401757],"domain_scores_gemma":[0.9990882,0.0000250817,0.0002690742,0.0004183933,0.00004911135,0.0001501596],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002979273,0.000117776,0.00005014351,0.002414422,0.0001359527,0.0001143867,0.00001743137,0.00000549613,0.009035739,0.00003318315,0.006373905,0.9816718],"study_design_scores_gemma":[0.0004574902,0.00009971999,0.000003673695,0.001663343,0.000290821,0.0001069723,0.000003396795,0.00000329255,0.00245484,0.00000653224,0.9944069,0.0005029548],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001350575,0.9974896,0.00004337139,0.00004905316,0.0003364748,0.0004478008,0.00007749473,0.00001289577,0.0001927413],"genre_scores_gemma":[0.0002561765,0.9919702,0.0002993509,0.00004977416,0.00111173,0.0001560511,0.0004326328,0.0001022282,0.005621865],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9880331,"threshold_uncertainty_score":0.9998052,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2030873172","doi":"10.1038/sj.leu.2402114","title":"Nucleoside analogues: mechanisms of drug resistance and reversal strategies","year":2001,"lang":"en","type":"review","venue":"Leukemia","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":492,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"National Cancer Institute; Ligue Contre le Cancer; Alberta Cancer Foundation; Friedreich's Ataxia Research Alliance","keywords":"Nucleoside transporter; Nucleoside analogue; Cladribine; Nucleoside; Fludarabine; Pharmacology; Intracellular; Transporter; Drug resistance; Gemcitabine; ATP-binding cassette transporter; Deoxycytidine kinase; Mechanism of action; Drug; Biology; Cancer research; Biochemistry; In vitro; Chemotherapy; Deoxycytidine; Genetics; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.01701804877374928,"gpt":0.2768646023809644,"spread":0.2598465536072151,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001383037,0.0002850483,0.0006826485,0.00005823994,0.00004413239,0.0000248144,0.0002262904,0.0003011491,0.00002037127],"category_scores_gemma":[0.00002523086,0.0002477253,0.0001947383,0.0001340376,0.00007705727,0.0000041555,0.0001075013,0.0001657196,0.000004230038],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003700673,"about_ca_system_score_gemma":0.0004069225,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004800784,"about_ca_topic_score_gemma":0.00002771071,"domain_scores_codex":[0.9988398,0.00007732303,0.0003801607,0.0003911282,0.0001127285,0.0001988363],"domain_scores_gemma":[0.9992409,0.00002696233,0.0002746666,0.000353546,0.00004348618,0.00006043523],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002692335,0.0001839472,0.00002855385,0.09403889,0.003091842,0.0005867819,0.0005379414,0.0001085414,0.009775454,0.03724694,0.5097771,0.3443548],"study_design_scores_gemma":[0.0001560177,0.00003659061,0.000001108851,0.00224926,0.0002598738,0.00003636666,0.0000871944,9.172454e-7,0.0004058673,0.0008632258,0.9956149,0.0002887207],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001462233,0.995676,0.001295043,0.000007872197,0.00007144993,0.0001599414,0.00003592931,0.00001059725,0.002596971],"genre_scores_gemma":[0.0005608881,0.9937378,0.00115576,0.00003777247,0.0002202356,0.00001387008,0.0002616542,0.0000411771,0.00397088],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4858378,"threshold_uncertainty_score":0.9999975,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2113661022","doi":"10.1073/pnas.1222251110","title":"CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer","year":2013,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":490,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Montreal Clinical Research Institute; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Anthracycline; Doxorubicin; Breast cancer; Triple-negative breast cancer; Chemotherapy; Medicine; Immune system; Cancer research; Cancer; Internal medicine; Oncology; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.01945924640970754,"gpt":0.2920652130715755,"spread":0.2726059666618679,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003145777,0.00006411343,0.00008901198,0.000051551,0.00006908726,0.00001400102,0.0002363016,0.00005614323,0.0000131715],"category_scores_gemma":[0.0001921702,0.00004220438,0.00002478375,0.0002914653,0.0004035349,0.00003147425,0.00008318698,0.00006223023,1.676156e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00000635432,"about_ca_system_score_gemma":0.00002435503,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004506681,"about_ca_topic_score_gemma":7.275768e-7,"domain_scores_codex":[0.9992595,0.00000476326,0.0001828475,0.0001859005,0.0002671765,0.00009983579],"domain_scores_gemma":[0.9995749,0.00002187579,0.0001895843,0.000003985624,0.0001896176,0.00002005197],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00002859181,0.00004605119,0.0556965,0.00005302972,0.00001184925,3.742544e-9,0.00008585834,0.00001295881,0.9393786,0.0008308763,0.003572144,0.0002835047],"study_design_scores_gemma":[0.0002313879,0.00003012271,0.2178587,0.0001000568,0.000004649234,0.000004267548,0.0001208598,0.0001963502,0.7758106,0.005509292,0.00006736343,0.00006634402],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9916614,0.0008708108,3.159156e-7,0.006628534,0.000006099012,0.000203248,0.00001681911,0.000001848377,0.0006109398],"genre_scores_gemma":[0.9985761,0.0001429587,0.0007619376,0.0001538663,0.00007259839,0.00003697304,1.77285e-7,0.000002719422,0.0002526492],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.163568,"threshold_uncertainty_score":0.1721045,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2049601932","doi":"10.1158/1078-0432.ccr-13-0545","title":"Targeting CD73 Enhances the Antitumor Activity of Anti-PD-1 and Anti-CTLA-4 mAbs","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":451,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"CTLA-4; Medicine; Pharmacology; Immunology; Cancer research; Immune system; T cell","retraction":null,"screen_n_in":null,"score":{"opus":0.09677112979043904,"gpt":0.4552541279929487,"spread":0.3584829982025097,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001600728,0.00009905105,0.0002161957,0.00003093306,0.0001749913,0.00004073217,0.0002865217,0.0001276493,0.0002224922],"category_scores_gemma":[0.0004286814,0.00006573006,0.00007485243,0.0001366606,0.0005916551,0.000009718762,0.0003120471,0.0003589211,0.00001606976],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000005746193,"about_ca_system_score_gemma":0.0001467897,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006194016,"about_ca_topic_score_gemma":0.000008199743,"domain_scores_codex":[0.9983853,0.0003572637,0.0003026205,0.0003599424,0.0002682366,0.000326634],"domain_scores_gemma":[0.9989353,0.0002934829,0.00009817139,0.0002867737,0.0002918908,0.00009437206],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00006082774,0.00007855242,0.04130513,0.00004969023,0.00005940394,0.000002329201,0.00002507137,0.00002363066,0.9345482,0.00002636477,0.02073754,0.003083249],"study_design_scores_gemma":[0.0007028026,0.0004237218,0.1113612,0.00006632739,0.00002068497,0.000004458892,0.0001797341,0.0003330624,0.8711779,0.0001814047,0.01532579,0.0002229751],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927225,0.005136814,0.0001131511,0.001297927,0.0001276157,0.0002522501,0.000008578231,0.000005023253,0.0003362153],"genre_scores_gemma":[0.9934437,0.005224481,0.00007939442,0.0001159281,0.0006915411,0.00004233493,0.0000063552,0.00001373078,0.0003825066],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07005605,"threshold_uncertainty_score":0.2680394,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1968323734","doi":"10.1053/j.gastro.2008.09.067","title":"Human Equilibrative Nucleoside Transporter 1 Levels Predict Response to Gemcitabine in Patients With Pancreatic Cancer","year":2008,"lang":"en","type":"article","venue":"Gastroenterology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":450,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"National Cancer Institute; National Institutes of Health","keywords":"Gemcitabine; Medicine; Hazard ratio; Internal medicine; Pancreatic cancer; Oncology; Proportional hazards model; Prospective cohort study; Gastroenterology; Confidence interval; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.01072693522538058,"gpt":0.23483535758684,"spread":0.2241084223614594,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000879348,0.0001774894,0.0002222327,0.00008845166,0.00005611986,0.000004042056,0.0001490596,0.00008072351,0.00009856847],"category_scores_gemma":[0.00001282947,0.0001520141,0.00004118042,0.00007722929,0.00008976093,0.000006960363,0.0000463558,0.00009645642,0.000003192248],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002034235,"about_ca_system_score_gemma":0.00004513404,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005163166,"about_ca_topic_score_gemma":0.0001311191,"domain_scores_codex":[0.9987968,0.000126006,0.000236622,0.0003560965,0.0001091475,0.0003753519],"domain_scores_gemma":[0.999554,0.000007260845,0.0000604618,0.0002214703,0.0000552795,0.0001014905],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005924631,0.0001181091,0.9549316,0.000005072737,0.00005994173,0.00003012423,0.0002107168,0.0004854459,0.03648915,0.000001828562,0.00173012,0.00001326926],"study_design_scores_gemma":[0.002928723,0.003258965,0.9903979,0.00002353529,0.0000174672,0.00001235023,0.00001681261,0.000005536738,0.002800556,0.000003449593,0.0004278095,0.0001069447],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9983701,0.00005045017,0.0008300524,0.0003217142,0.00003958496,0.0002628382,0.00006643618,0.00001149799,0.00004733568],"genre_scores_gemma":[0.998074,0.00000406708,0.000331576,0.001120016,0.00008692296,0.0000701372,0.00007620486,0.0000264522,0.000210607],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03546626,"threshold_uncertainty_score":0.6198956,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2131555383","doi":"10.1158/1078-0432.ccr-04-0224","title":"The Absence of Human Equilibrative Nucleoside Transporter 1 Is Associated with Reduced Survival in Patients With Gemcitabine-Treated Pancreas Adenocarcinoma","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":425,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Alberta","funders":"","keywords":"Gemcitabine; Pancreatic cancer; Adenocarcinoma; Nucleoside analogue; Immunohistochemistry; Medicine; Nucleoside transporter; Internal medicine; Oncology; Chemotherapy; Nucleoside; Cancer; Pathology; Cancer research; Gastroenterology; Biology; Transporter","retraction":null,"screen_n_in":null,"score":{"opus":0.06715783176234653,"gpt":0.3910521475534355,"spread":0.323894315791089,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000888333,0.0001471518,0.0002746513,0.00004369385,0.0001435595,0.00002130067,0.0003283645,0.0001581812,0.00003545627],"category_scores_gemma":[0.0001319101,0.00009026466,0.00006676433,0.0003724062,0.0006038671,0.000009276426,0.00006506736,0.0004034909,0.000001453811],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004593565,"about_ca_system_score_gemma":0.0003363734,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007955767,"about_ca_topic_score_gemma":0.0007958033,"domain_scores_codex":[0.9979188,0.0002952049,0.0004391648,0.0004347088,0.0004905972,0.0004214878],"domain_scores_gemma":[0.9987423,0.0001711869,0.0001310052,0.0003574943,0.000487394,0.0001105558],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002163768,0.0002960472,0.989722,0.00001038181,0.0001917234,0.00001474286,0.0001463663,0.00005387404,0.006903121,0.00006253567,0.0003204955,0.0001149899],"study_design_scores_gemma":[0.004163974,0.002374351,0.9709043,0.0001595378,0.00001929735,3.239722e-7,0.0001139681,0.000003699082,0.02192826,0.0001170961,0.00006048481,0.0001547206],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9983968,0.0005712774,0.000009537143,0.000299124,0.00002545536,0.0003529353,0.00003828479,0.0000061045,0.0003005263],"genre_scores_gemma":[0.9993653,0.0001035812,0.00001951231,0.00005859277,0.00009285618,0.00004598975,0.00007438023,0.00002875137,0.000211065],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01881767,"threshold_uncertainty_score":0.3680886,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1997319017","doi":"10.1182/blood-2010-08-265892","title":"Cytokine release from innate immune cells: association with diverse membrane trafficking pathways","year":2011,"lang":"en","type":"review","venue":"Blood","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":398,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Innate immune system; Cytokine; Immune system; Biology; Cell biology; Immunology; Innate lymphoid cell; CCL18; Signal transduction; Acquired immune system; Inflammation","retraction":null,"screen_n_in":null,"score":{"opus":0.02166237855783743,"gpt":0.2294235831064147,"spread":0.2077612045485773,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001725583,0.0004122647,0.0007766594,0.00006280345,0.00008677569,0.00003099884,0.000301769,0.0005417622,0.00007855015],"category_scores_gemma":[0.00004370125,0.0003311733,0.0003149291,0.0001364623,0.00002320618,0.000004641006,0.0001289635,0.0002909528,0.00004549423],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002605058,"about_ca_system_score_gemma":0.0001715665,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001055811,"about_ca_topic_score_gemma":0.000006447522,"domain_scores_codex":[0.9984452,0.0001354104,0.0004168662,0.0005228128,0.000173295,0.000306399],"domain_scores_gemma":[0.9987792,0.00003674308,0.0005733253,0.0004404289,0.00008342839,0.00008683269],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006430964,0.005832612,0.0004547095,0.02037147,0.02379776,0.001735345,0.001601887,0.0001382488,0.1363685,0.0001867339,0.01543084,0.7934388],"study_design_scores_gemma":[0.001220386,0.0002193369,0.00000371645,0.001907987,0.002740635,0.00002324746,0.00002424607,0.000001215896,0.03485612,0.000003365376,0.958399,0.0006007191],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01075487,0.9878471,0.00004872788,0.000002652433,0.0001453203,0.0002837062,0.0002664831,0.00003493866,0.0006161773],"genre_scores_gemma":[0.005174816,0.991468,0.0002930742,0.00002820254,0.0007430704,0.00003790092,0.001718884,0.00008338897,0.000452718],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9429682,"threshold_uncertainty_score":0.9999141,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2168786562","doi":"10.1158/0008-5472.can-10-4246","title":"CD73-Deficient Mice Have Increased Antitumor Immunity and Are Resistant to Experimental Metastasis","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":393,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Immune system; Cancer research; Metastasis; Melanoma; CD8; Adoptive cell transfer; Immunology; Cytotoxic T cell; Biology; Cancer immunotherapy; Immunotherapy; Cancer; T cell; In vitro","retraction":null,"screen_n_in":null,"score":{"opus":0.1085437339786479,"gpt":0.3827667634199589,"spread":0.274223029441311,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004825305,0.000108571,0.0001227224,0.00008770647,0.0002021036,0.00002952316,0.0002116528,0.00005615567,0.0001739365],"category_scores_gemma":[0.00006254064,0.00009850044,0.00003692162,0.0001354212,0.0001253753,0.000003897363,0.0003218667,0.0001426959,0.000009424675],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003794744,"about_ca_system_score_gemma":0.00009834329,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003398018,"about_ca_topic_score_gemma":0.000104962,"domain_scores_codex":[0.9988168,0.0001680978,0.0001279769,0.0003270456,0.0002253711,0.0003346991],"domain_scores_gemma":[0.9993181,0.00001603902,0.00003065421,0.0002958099,0.000164367,0.0001750617],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005367108,0.00009115614,0.001995668,0.000019871,0.00004515644,0.0000216148,0.000395316,0.000003454569,0.9905567,0.00003821519,0.006192864,0.0001032269],"study_design_scores_gemma":[0.0003377991,0.0003219383,0.004012601,0.00003390262,0.000009890738,0.000006349439,0.002250331,0.000003924901,0.9829151,0.000009559632,0.009961331,0.0001372895],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9856904,0.01280413,0.00003397205,0.00009320388,0.0000364174,0.0002074563,0.00004851565,0.000006597357,0.001079378],"genre_scores_gemma":[0.998647,0.0002142506,0.000301659,0.0001389098,0.0001092531,0.00009727712,0.00001340731,0.00001880621,0.0004594035],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01295671,"threshold_uncertainty_score":0.5136809,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1974409640","doi":"10.1016/j.it.2012.02.009","title":"CD73: a potent suppressor of antitumor immune responses","year":2012,"lang":"en","type":"review","venue":"Trends in Immunology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":365,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Health and Medical Research Council; National Medical Research Council; Medical Research Council; Victorian Cancer Agency","keywords":"Immunosurveillance; Adenosine; Immune system; Cancer research; Immunology; Tumor microenvironment; 5'-nucleotidase; Myeloid-derived Suppressor Cell; Carcinogenesis; Biology; Suppressor; Nucleotidase; Cancer; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.05217649283058647,"gpt":0.3429936773554892,"spread":0.2908171845249027,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002847859,0.0003834247,0.001299544,0.0004913957,0.00003100423,0.000005931177,0.0005034495,0.0006315882,0.0002117114],"category_scores_gemma":[0.00006525491,0.0003287445,0.0004559204,0.0003114652,0.0001887994,0.000003335247,0.0003370356,0.0003282342,0.00002179573],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002345087,"about_ca_system_score_gemma":0.0001236131,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006109882,"about_ca_topic_score_gemma":0.000003816879,"domain_scores_codex":[0.9978842,0.0003853879,0.0008020512,0.0003904119,0.00008867672,0.0004493167],"domain_scores_gemma":[0.9987074,0.00006113886,0.0004274486,0.0007285691,0.00004011812,0.00003529486],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003321038,0.0003597833,0.00005465773,0.001884395,0.0008090628,0.00005253455,0.00006378639,0.000002586884,0.01248308,0.0002597072,0.001644846,0.9820535],"study_design_scores_gemma":[0.0004303566,0.0002522729,0.0001566239,0.0008342962,0.0002969248,0.0002323672,0.00001340088,2.274806e-7,0.003575489,0.000006206476,0.993866,0.0003358907],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001827403,0.9966208,0.00001355437,0.00001756549,0.0003903759,0.0001256906,0.00007463211,0.00001011877,0.0009198831],"genre_scores_gemma":[0.009384843,0.986248,0.0001687766,0.000009965665,0.0002142001,0.00006132606,0.0006320468,0.00005630689,0.003224516],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9922211,"threshold_uncertainty_score":0.9999164,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1994440562","doi":"10.1038/nn1498","title":"Norepinephrine triggers release of glial ATP to increase postsynaptic efficacy","year":2005,"lang":"en","type":"article","venue":"Nature Neuroscience","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":363,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Saskatchewan; University of Calgary","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Postsynaptic potential; Excitatory postsynaptic potential; Neuroscience; Neurotransmission; AMPA receptor; Postsynaptic Current; Postsynaptic density; Glutamatergic; Silent synapse; Post-tetanic potentiation; Chemistry; Biology; Glutamate receptor; Inhibitory postsynaptic potential; Receptor; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.006103434583018467,"gpt":0.2661957940920709,"spread":0.2600923595090524,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001219124,0.0001353519,0.0001287755,0.00007371637,0.0000629422,0.00001382488,0.0003619164,0.0001483041,0.00001552229],"category_scores_gemma":[0.0009198994,0.0001204575,0.00007529225,0.0003320068,0.00008840232,0.000006900098,0.0001375957,0.0002018078,0.000008824231],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000008706167,"about_ca_system_score_gemma":0.00008033062,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001300349,"about_ca_topic_score_gemma":0.000002569665,"domain_scores_codex":[0.9988893,0.00003367599,0.0001907227,0.0004140357,0.0002303149,0.000241905],"domain_scores_gemma":[0.9993066,0.00002392557,0.00007216567,0.0003396474,0.00008545809,0.0001721569],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001985908,0.00008833217,0.0002648642,0.000006052858,0.000002481949,0.00001138787,0.00002194002,0.001375021,0.9907423,0.00006112404,0.005941471,0.001286389],"study_design_scores_gemma":[0.0009581099,0.0007123624,0.007407325,0.00001978693,0.00001943163,0.000073782,0.000008027447,0.0005576978,0.7880788,0.000005437924,0.2018741,0.0002850679],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973046,0.0006600049,0.0002878732,0.0009532861,0.0002001153,0.0001458029,0.00001441649,0.00001529514,0.0004185608],"genre_scores_gemma":[0.9936991,0.00003196136,0.0007202533,0.004635541,0.0004111304,0.000003981439,0.00001057508,0.00001332566,0.0004740717],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2026635,"threshold_uncertainty_score":0.4912113,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1975172757","doi":"10.1038/nm.2710","title":"Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity","year":2012,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":362,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Hospital for Sick Children; McGill University","funders":"Canadian Institutes of Health Research; National Institutes of Health; National Institute of Neurological Disorders and Stroke; Howard Hughes Medical Institute","keywords":"Chronic pain; Allodynia; Allele; Cohort; Analgesic; Neuropathic pain; Medicine; Receptor; Internal medicine; Gene; Biology; Anesthesia; Genetics; Nociception; Neuroscience; Hyperalgesia","retraction":null,"screen_n_in":null,"score":{"opus":0.006014704519862007,"gpt":0.2533890753674685,"spread":0.2473743708476065,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002662216,0.0001533996,0.0001859853,0.00005095743,0.00003743273,0.000003862255,0.00007644198,0.0004115381,0.00007823249],"category_scores_gemma":[0.001181672,0.0001199916,0.0000405661,0.000137049,0.00007967695,0.000009114242,0.00004865188,0.0002903567,0.000003284916],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006678301,"about_ca_system_score_gemma":0.00005077586,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001459359,"about_ca_topic_score_gemma":0.00001691009,"domain_scores_codex":[0.9986612,0.0004006075,0.0002522517,0.0002174465,0.0001633437,0.0003051842],"domain_scores_gemma":[0.9993497,0.0001201465,0.00007511445,0.0002717478,0.00007751172,0.0001057564],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00009003098,0.00005162782,0.005910096,0.0000739221,0.00001688933,0.00000615078,0.0001365639,0.00003617485,0.9667886,0.0000904749,0.01347945,0.01332005],"study_design_scores_gemma":[0.002725481,0.0009212909,0.03846717,0.0002758327,0.00007287599,0.0001473512,0.0001358432,0.004859578,0.8566455,0.0004714168,0.0946227,0.0006550201],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9848285,0.006573796,0.006473046,0.001123141,0.0002595918,0.0002093332,0.000004972713,0.00001710943,0.0005105542],"genre_scores_gemma":[0.9958605,0.00009157689,0.0008082289,0.0007474055,0.001997997,0.000009266991,0.000366359,0.00001406656,0.0001045546],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1101431,"threshold_uncertainty_score":0.4893117,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2088291447","doi":"10.1016/s0301-0082(03)00050-9","title":"Adenosine in the spinal cord and periphery: release and regulation of pain","year":2003,"lang":"en","type":"review","venue":"Progress in Neurobiology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":355,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children; Dalhousie University","funders":"","keywords":"Adenosine; Adenosine kinase; Adenosine receptor; Purinergic signalling; Adenosine A1 receptor; Adenosine deaminase; Extracellular; Adenosine A2B receptor; Adenosine A3 receptor; Chemistry; Capsaicin; Neuroscience; Purinergic receptor; Nociceptor; Pharmacology; Receptor; Biology; Nociception; Biochemistry; Agonist","retraction":null,"screen_n_in":null,"score":{"opus":0.02836256765604249,"gpt":0.3208350418442221,"spread":0.2924724741881796,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005177552,0.0002085342,0.0005069374,0.00008422349,0.00002166146,0.00000920396,0.0001453034,0.0002858162,0.000003604677],"category_scores_gemma":[0.00008540504,0.0001469705,0.00005545621,0.0001423053,0.0002330442,0.000001988203,0.00007746646,0.0002018397,2.089577e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00000432065,"about_ca_system_score_gemma":0.00005157365,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004203658,"about_ca_topic_score_gemma":0.000004005867,"domain_scores_codex":[0.9981588,0.0008741664,0.0003765495,0.0003723665,0.00004010363,0.0001779989],"domain_scores_gemma":[0.9994816,0.00005221299,0.0002075695,0.0002172138,0.00001929081,0.00002206567],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001683312,0.00008992162,0.003568151,0.003651126,0.00002938117,0.00002649043,0.00002173288,0.000001317048,0.00008044811,0.0002420739,0.0004654208,0.9916556],"study_design_scores_gemma":[0.0004722255,0.001845609,0.001466641,0.002039509,0.00009678214,0.0003821641,0.00002201911,0.00001039664,0.00003778739,0.00006278382,0.9932513,0.000312755],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01571815,0.9837629,0.00001150081,0.00004422636,0.00004807051,0.0003770341,0.000006124604,0.000002248644,0.00002974547],"genre_scores_gemma":[0.05214814,0.9473798,0.00009870368,0.00009943243,0.00007331516,0.00007357929,0.00008589921,0.00001887434,0.00002223267],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9927859,"threshold_uncertainty_score":0.5993283,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1969211295","doi":"10.1016/j.mam.2012.05.007","title":"The human concentrative and equilibrative nucleoside transporter families, SLC28 and SLC29","year":2013,"lang":"en","type":"review","venue":"Molecular Aspects of Medicine","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":351,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Cancer Society Research Institute; Alberta Cancer Foundation; Canadian Institutes of Health Research; British Heart Foundation; Wellcome Trust; Medical Research Council; Cancer Research Institute","keywords":"Nucleoside transporter; Nucleoside; Transporter; Adenosine; Nucleobase; Nucleotide; Biochemistry; Nucleoside analogue; Biology; Chemistry; Gene; DNA","retraction":null,"screen_n_in":null,"score":{"opus":0.01869179068290828,"gpt":0.3006883102729677,"spread":0.2819965195900594,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002005687,0.0004147275,0.0009329781,0.00005543262,0.0001217151,0.00001967681,0.0002378566,0.0002486649,0.00002922711],"category_scores_gemma":[0.00006426068,0.0002479065,0.0001330186,0.000102292,0.0009194895,0.000005056048,0.00008792159,0.0002360213,0.000001094375],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00000877149,"about_ca_system_score_gemma":0.00009730548,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005262759,"about_ca_topic_score_gemma":0.000005073195,"domain_scores_codex":[0.9983532,0.0001607589,0.000539456,0.0004663561,0.0002137753,0.0002664954],"domain_scores_gemma":[0.9990045,0.00007281276,0.0003249945,0.0003780246,0.00009017692,0.0001294823],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000986362,0.000200632,0.00005446378,0.01555379,0.005203371,0.0009154819,0.001913557,0.000003499348,0.1674125,0.07317714,0.03991369,0.6955532],"study_design_scores_gemma":[0.001071795,0.0007512164,0.00001923589,0.003325343,0.0008534613,0.000196496,0.000330998,0.000003193789,0.004500172,0.0008753576,0.9876212,0.0004515268],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002615718,0.993134,0.0002421099,0.0003217845,0.00004894431,0.0006479289,0.00001199644,0.000007878687,0.002969702],"genre_scores_gemma":[0.01436458,0.9847138,0.00007182275,0.0001635134,0.0002280936,0.00004308129,0.0001545835,0.00005091903,0.0002096236],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9477075,"threshold_uncertainty_score":0.9999973,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2088277236","doi":"10.1002/ana.21315","title":"Adenosine A <sub>2A</sub> receptor antagonist istradefylline (KW‐6002) reduces “off” time in Parkinson's disease: A double‐blind, randomized, multicenter clinical trial (6002‐US‐005)","year":2008,"lang":"en","type":"article","venue":"Annals of Neurology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":350,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Placebo; Randomization; Randomized controlled trial; Adverse effect; Clinical Global Impression; Clinical endpoint; Confidence interval; Clinical trial; Anesthesia; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.06761578781320707,"gpt":0.3404442775767428,"spread":0.2728284897635357,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00101577,0.0004309879,0.001138897,0.000176121,0.0001094521,0.00002002056,0.0004671624,0.0005022087,0.00009055668],"category_scores_gemma":[0.0006452826,0.0003958177,0.0006463678,0.0002188904,0.0007757847,0.00001813601,0.0001952897,0.0004694089,0.00005220746],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000004203024,"about_ca_system_score_gemma":0.0001960818,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002692625,"about_ca_topic_score_gemma":0.000006640082,"domain_scores_codex":[0.9957556,0.0008755489,0.001467841,0.0009579883,0.000283307,0.0006597682],"domain_scores_gemma":[0.9981267,0.0003100254,0.0005715314,0.0005034468,0.0001743372,0.0003139756],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.88143,0.001293308,0.002359993,0.00002792191,0.0002117074,0.0002167588,0.00003757732,0.0001641569,0.07167307,0.00001172354,0.04207164,0.0005021786],"study_design_scores_gemma":[0.6738876,0.003517224,0.002173994,0.00005247059,0.0001649634,0.0001221291,0.000007536545,0.0006409078,0.1890097,0.00005214625,0.1295997,0.0007716143],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9862587,0.006196716,0.00003162902,0.005719921,0.000493102,0.00106069,0.00008069802,0.00002837529,0.0001301537],"genre_scores_gemma":[0.9830151,0.01110186,0.00008191462,0.003231215,0.001785021,0.0001140023,0.0003761652,0.0000606091,0.0002341096],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2075424,"threshold_uncertainty_score":0.9998494,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2141035582","doi":"10.1084/jem.20050177","title":"HIF-1–dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia","year":2005,"lang":"en","type":"article","venue":"The Journal of Experimental Medicine","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":346,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"York University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute","keywords":"Hypoxia (environmental); Extracellular; Cell biology; Adenosine; Biology; Psychological repression; Signal transduction; Nucleoside; Biochemistry; Chemistry; Gene expression; Oxygen; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.01401936638685789,"gpt":0.2892436357612291,"spread":0.2752242693743712,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003522536,0.0000948936,0.0001911626,0.00004880143,0.00002127703,0.000001485939,0.0001866843,0.00004737558,0.0002096727],"category_scores_gemma":[0.00002292015,0.00005421914,0.00005240714,0.00005606455,0.0001017072,0.000009340749,0.00003351136,0.0001123151,8.28817e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001591009,"about_ca_system_score_gemma":0.00002403097,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002152874,"about_ca_topic_score_gemma":0.00000286094,"domain_scores_codex":[0.9990808,0.00007252634,0.0004518204,0.00008026598,0.0002089962,0.00010558],"domain_scores_gemma":[0.9994921,0.00002346605,0.000252271,0.0001433328,0.00003800731,0.0000507986],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005921163,0.0001126424,0.0003769718,0.000003421284,0.00003018474,0.00001066254,0.00178832,0.0002263148,0.9942241,0.00001866041,0.002350054,0.0002665702],"study_design_scores_gemma":[0.001659807,0.000985225,0.001362332,0.0001453686,0.0000250286,0.0001166025,0.002166584,0.00003291551,0.9924799,0.00003003144,0.0009358921,0.00006028583],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9786621,0.01910963,0.0002502736,0.0008683436,0.00009347896,0.00007102371,0.000001057784,0.000001133737,0.0009429208],"genre_scores_gemma":[0.9985125,0.0003233372,0.0002243065,0.0002703241,0.0005307433,9.910419e-7,0.000003361335,0.00000957152,0.0001248846],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01985034,"threshold_uncertainty_score":0.2295769,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2030272844","doi":"10.1073/pnas.1308209110","title":"Blockade of A <sub>2A</sub> receptors potently suppresses the metastasis of CD73 <sup>+</sup> tumors","year":2013,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":343,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Medical Research Council; Canadian Institutes of Health Research; National Health and Medical Research Council; Peter MacCallum Cancer Centre; U.S. Department of Defense","keywords":"Metastasis; Adenosine A2A receptor; Cancer research; Granzyme B; Receptor; Biology; Granzyme; Immune system; Immunotherapy; Immunology; Adenosine receptor; Perforin; T cell; CD8; Cancer; Agonist; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.01940862774821595,"gpt":0.257224147289217,"spread":0.2378155195410011,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007270073,0.0001130883,0.000184314,0.00008993137,0.0001082557,0.00001251717,0.0008670026,0.00008791161,0.00003092305],"category_scores_gemma":[0.0005314533,0.00006539496,0.0001365972,0.0004572147,0.0008910751,0.00003319975,0.0002108083,0.00010321,7.155368e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000005456946,"about_ca_system_score_gemma":0.00004992765,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002381623,"about_ca_topic_score_gemma":3.085942e-8,"domain_scores_codex":[0.9984832,0.00001492211,0.000409452,0.0002180507,0.0007182749,0.0001561433],"domain_scores_gemma":[0.9988801,0.00007425751,0.0005366208,0.00002114487,0.0004563026,0.00003154794],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0000147513,0.00004231317,0.002177764,0.00005942589,0.00004943045,2.637328e-9,0.0001209477,0.00095632,0.9883169,0.0009592733,0.007070412,0.0002324446],"study_design_scores_gemma":[0.0001235436,0.00008993444,0.002991379,0.00005798435,0.00002843967,0.000006236289,0.0005405991,0.0003104561,0.9925241,0.002971277,0.0002848817,0.00007114976],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963645,0.0008697907,0.000002706355,0.00169353,0.00001119564,0.0001752999,0.00002092403,0.000002714903,0.0008592924],"genre_scores_gemma":[0.9990299,0.0001221537,0.0005297884,0.0001213603,0.00009453952,0.00001368554,7.987521e-7,0.00000561792,0.00008217614],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006785531,"threshold_uncertainty_score":0.3283203,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2987822998","doi":"10.1158/2159-8290.cd-19-0980","title":"Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":339,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Regional Cancer Foundation; Ottawa Hospital; Spinal Cord Injury BC; BC Cancer Agency","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health","keywords":"Immunotherapy; Medicine; Adenosine; Immune system; Adenosine receptor; Cancer immunotherapy; Immune checkpoint; Cancer research; Tumor microenvironment; Adenosinergic; Immunology; Internal medicine; Receptor","retraction":null,"screen_n_in":null,"score":{"opus":0.01063077721363765,"gpt":0.283419011275283,"spread":0.2727882340616453,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004761104,0.0002495085,0.0002301799,0.00003411797,0.00007749776,0.00005234207,0.0001936147,0.0001602395,0.0006431202],"category_scores_gemma":[0.000003999156,0.0002114293,0.0001619255,0.00006027126,0.00003921143,0.00002750655,0.00002863348,0.0000530834,0.00002175109],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009660257,"about_ca_system_score_gemma":0.0003625743,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005711819,"about_ca_topic_score_gemma":0.00003944534,"domain_scores_codex":[0.9988587,0.00003108013,0.0001920741,0.0004884488,0.0001065084,0.0003231925],"domain_scores_gemma":[0.9993273,0.00001639995,0.0001193782,0.0003931072,0.00006032513,0.00008346775],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000849343,0.0001666735,0.003412192,0.00002906847,0.0001562366,0.000001001123,0.0001067687,0.0005598055,0.9787319,0.00002069754,0.01336316,0.002603187],"study_design_scores_gemma":[0.00183176,0.001037928,0.0002444234,0.00002995161,0.00003878901,0.000001501804,0.00006850996,0.00001923873,0.6401092,0.00002053933,0.3563247,0.0002735003],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9659047,0.03177043,0.0002546253,0.0002029668,0.0006235345,0.0004228791,0.0002843134,0.00001627531,0.0005203412],"genre_scores_gemma":[0.9524963,0.007228506,0.000143172,0.0006784621,0.001983244,0.0003595623,0.0004620442,0.00007378402,0.03657491],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3429615,"threshold_uncertainty_score":0.8621835,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2016300311","doi":"10.1007/s11302-005-6217-x","title":"Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8","year":2005,"lang":"en","type":"article","venue":"Purinergic Signalling","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":336,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre hospitalier de l'Université Laval","funders":"Canadian Institutes of Health Research; Hydro-Québec; Arthritis Society","keywords":"Apyrase; Receptor; P2 receptor; Nucleoside triphosphate; Chemistry; Divalent; P2Y receptor; ATP hydrolysis; Nucleotide; Nucleoside; Adenosine; 5'-nucleotidase; Biochemistry; Enzyme; Biophysics; Purinergic receptor; Biology; ATPase","retraction":null,"screen_n_in":null,"score":{"opus":0.01057084338964184,"gpt":0.2461549997679736,"spread":0.2355841563783317,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001445832,0.0002007122,0.000292502,0.00005311361,0.00008368969,0.00002051242,0.0001538558,0.0001038253,0.0001411053],"category_scores_gemma":[0.00002380778,0.000190151,0.00008970276,0.0001097229,0.00009747598,0.000008704619,0.0000856886,0.00008635293,0.000009375373],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000008957543,"about_ca_system_score_gemma":0.00002864243,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002925252,"about_ca_topic_score_gemma":0.000002987638,"domain_scores_codex":[0.998885,0.00005110386,0.0003198184,0.0003506973,0.0001551017,0.0002382568],"domain_scores_gemma":[0.9994529,0.00003979663,0.0001484922,0.0001748061,0.00008004396,0.0001039839],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00008670889,0.0001030492,0.000848542,0.00002317876,0.0001360722,0.00000128403,0.0001561465,0.003872137,0.9702502,0.00006772052,0.02366016,0.0007948056],"study_design_scores_gemma":[0.0006212023,0.0001878397,0.00007378886,0.00002964419,0.00004564103,0.00001172315,0.000106951,0.001345709,0.92794,0.00002893861,0.06932651,0.0002821231],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9773751,0.01952802,0.001463778,0.0001922958,0.00003698731,0.000101142,0.00002693219,0.00001676105,0.001258969],"genre_scores_gemma":[0.9957353,0.0006330189,0.001629198,0.0001357479,0.0003814569,0.0000158337,0.0001397161,0.00002019201,0.001309496],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04566635,"threshold_uncertainty_score":0.7754132,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2101017561","doi":"10.1074/jbc.m007746200","title":"Molecular Identification and Characterization of Novel Human and Mouse Concentrative Na+-Nucleoside Cotransporter Proteins (hCNT3 and mCNT3) Broadly Selective for Purine and Pyrimidine Nucleosides (System cib)","year":2001,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":334,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"National Cancer Institute; Medical Research Council; Wellcome Trust; Hospital for Sick Children; Fondation pour la Recherche Médicale; Natural Sciences and Engineering Research Council of Canada","keywords":"Biology; Biochemistry; Symporter; Nucleoside; Molecular biology; Uridine; RNA; Gene; Transporter","retraction":null,"screen_n_in":null,"score":{"opus":0.01603007792055538,"gpt":0.2468252188415413,"spread":0.2307951409209859,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001867327,0.0001496446,0.0002595966,0.00002052691,0.00007274867,0.00002679916,0.00006002135,0.0001775593,0.00000268219],"category_scores_gemma":[0.00005172942,0.0001191574,0.00004490963,0.00004260195,0.0001761,0.00001557694,0.00003379833,0.0000932252,1.583622e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001048397,"about_ca_system_score_gemma":0.00001895839,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002975063,"about_ca_topic_score_gemma":3.300327e-7,"domain_scores_codex":[0.9991268,0.00002220924,0.0004014268,0.0002384972,0.00007542683,0.0001356573],"domain_scores_gemma":[0.9992148,0.0000182373,0.000396881,0.000073428,0.000198735,0.00009789725],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002790334,0.00006732103,0.00800691,0.0001292165,0.0000757729,0.000006019466,0.00005959287,0.000003191404,0.991163,0.00003433687,0.00000820572,0.0001673846],"study_design_scores_gemma":[0.001211654,0.000418617,0.01837953,0.00006427061,0.00005218598,0.0002402243,0.0001481247,0.00009043326,0.9791149,0.00002279689,0.0001225005,0.0001347068],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944949,0.001024878,0.004101018,0.00008074513,0.0000112822,0.0002154301,0.00004646208,0.000004878582,0.00002042168],"genre_scores_gemma":[0.998826,0.0004968388,0.000408836,0.00003455549,0.0001078103,0.000009022464,0.00007157627,0.00001094635,0.00003440649],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01204806,"threshold_uncertainty_score":0.48591,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2160141570","doi":"10.1158/2326-6066.cir-14-0211","title":"Adenosine Receptor 2A Blockade Increases the Efficacy of Anti–PD-1 through Enhanced Antitumor T-cell Responses","year":2015,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":329,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Peter MacCallum Cancer Centre","keywords":"Adenosine A2A receptor; Immunotherapy; Granzyme B; Medicine; Blockade; CD8; Immune system; Adenosine receptor; Cancer research; T cell; Pharmacology; Immunology; Receptor expression; Tumor microenvironment; Cancer immunotherapy; Cytotoxic T cell; Receptor; Biology; Internal medicine; In vitro","retraction":null,"screen_n_in":null,"score":{"opus":0.07078595446986687,"gpt":0.3789836790052267,"spread":0.3081977245353598,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008908645,0.0001853353,0.0002802732,0.00009543976,0.0002044156,0.00002293661,0.0007160173,0.0002231113,0.0001471155],"category_scores_gemma":[0.0008120293,0.0001375186,0.00009236031,0.0004213229,0.0009318609,0.000009776417,0.0004358312,0.0004067057,0.00004309052],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000412012,"about_ca_system_score_gemma":0.0007932055,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007468748,"about_ca_topic_score_gemma":0.00001037377,"domain_scores_codex":[0.9976489,0.0007182672,0.0003220406,0.0004343273,0.0003292172,0.0005472605],"domain_scores_gemma":[0.9981657,0.0002954011,0.0001243904,0.0007073724,0.0006288275,0.00007834331],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00177191,0.0001980795,0.001808939,0.00002168993,0.0001537777,0.00000633682,0.0002869514,0.00006250846,0.9564108,0.00005351617,0.03898257,0.0002428668],"study_design_scores_gemma":[0.001609595,0.0006600717,0.002037791,0.00004608481,0.0000238457,0.00001616658,0.0006252074,0.000003133054,0.9382427,0.00005044651,0.05652625,0.0001586655],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9245923,0.07277537,0.00008653452,0.0009890234,0.0002201896,0.0003012503,0.00003860111,0.00001471804,0.0009820365],"genre_scores_gemma":[0.9904926,0.005029657,0.0001583965,0.0001110437,0.0005415787,0.00008850887,0.00005801391,0.00003342236,0.003486809],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06774572,"threshold_uncertainty_score":0.5607844,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2042464260","doi":"10.1074/jbc.m414337200","title":"Functional Characterization of Novel Human and Mouse Equilibrative Nucleoside Transporters (hENT3 and mENT3) Located in Intracellular Membranes","year":2005,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":322,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Nucleoside; Nucleoside transporter; Transporter; Transport protein; Biochemistry; Biology; Endosome; Intracellular; Molecular biology; Cell biology; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.01951337139142346,"gpt":0.2303802624347079,"spread":0.2108668910432845,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001308583,0.0001010922,0.0001748804,0.00002227482,0.00002216136,0.000007567804,0.00005964162,0.0001465297,0.00004676557],"category_scores_gemma":[0.00001996784,0.00007830203,0.00004222021,0.00003915542,0.00009063751,0.00001081553,0.00002347583,0.0001065028,5.823052e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000007200263,"about_ca_system_score_gemma":0.0000171195,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002058333,"about_ca_topic_score_gemma":4.652526e-7,"domain_scores_codex":[0.9993374,0.00001556703,0.0003477825,0.000132843,0.00007231664,0.00009403272],"domain_scores_gemma":[0.9996154,0.000010066,0.0002122719,0.00005018185,0.00005412488,0.00005796677],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001713231,0.0001262091,0.005407649,0.00003625521,0.0000343007,0.000003687842,0.00004049312,0.00007642612,0.9939443,0.000005701058,0.00001361481,0.0001400005],"study_design_scores_gemma":[0.0009257548,0.0001427704,0.01559441,0.00002649107,0.00001401292,0.00005986395,0.0000738919,0.00008225886,0.9826796,0.000006550344,0.0003058915,0.00008848021],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980173,0.0009268404,0.000850967,0.0001190024,0.00001027879,0.0000373317,0.00001290329,0.00000206271,0.00002335697],"genre_scores_gemma":[0.9989911,0.0004550053,0.0001765759,0.00004921571,0.0001663246,0.000001054564,0.00009829846,0.000005475579,0.00005697877],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01126472,"threshold_uncertainty_score":0.3193064,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2063226474","doi":"10.1038/sj.onc.1206952","title":"Nucleoside anticancer drugs: the role of nucleoside transporters in resistance to cancer chemotherapy","year":2003,"lang":"en","type":"review","venue":"Oncogene","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":316,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Cancer Foundation; University of Alberta","funders":"","keywords":"Nucleoside; Nucleoside transporter; Biology; Nucleoside analogue; Efflux; Pharmacology; Drug resistance; Transporter; Antimetabolite; Prodrug; Cancer; Biochemistry; Genetics; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.01262386897296735,"gpt":0.3035852269632324,"spread":0.290961357990265,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002237232,0.0003392951,0.0007909358,0.00007181388,0.0000406873,0.00001095551,0.0004212359,0.0002511824,0.00008884292],"category_scores_gemma":[0.00001052411,0.0002513407,0.0003229928,0.0003312542,0.00006678171,0.000002329938,0.00002885774,0.0001594373,0.000004849294],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005007557,"about_ca_system_score_gemma":0.0003146004,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001234711,"about_ca_topic_score_gemma":0.0001738378,"domain_scores_codex":[0.9983871,0.0000971821,0.0005430953,0.0004714213,0.000187414,0.0003138118],"domain_scores_gemma":[0.9990812,0.00002445514,0.0002396097,0.0005285201,0.0000496869,0.00007655106],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001888518,0.0001764211,0.0001530136,0.002730267,0.0006237087,0.00001753958,0.0005673046,0.0001292238,0.02478842,0.0001245459,0.0149544,0.9555463],"study_design_scores_gemma":[0.0002276451,0.00003605397,0.000004000474,0.001812785,0.0001472019,0.000002897112,0.00007236493,5.206048e-7,0.01373917,0.00001814261,0.9836461,0.000293149],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002875688,0.9942809,0.00003255723,0.00009930716,0.0001033137,0.0004968991,0.00008768283,0.000005066967,0.002018625],"genre_scores_gemma":[0.003023142,0.9945223,0.0002653487,0.0005808433,0.0003092408,0.0001430647,0.00004581856,0.00008297988,0.001027316],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9686916,"threshold_uncertainty_score":0.9999939,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2097677296","doi":"10.1136/annrheumdis-2011-143578","title":"Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":310,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Placebo; Rheumatoid arthritis; Etanercept; Internal medicine; Rheumatology; Methotrexate; Discontinuation; Gastroenterology; Placebo-controlled study; Pathology; Double blind","retraction":null,"screen_n_in":null,"score":{"opus":0.04058819895899907,"gpt":0.3226859953672563,"spread":0.2820977964082572,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005022481,0.0001891506,0.0003403806,0.00002570384,0.00007782527,0.000006841455,0.0002786148,0.00004225258,0.00002896728],"category_scores_gemma":[0.0006690639,0.00006968741,0.0001847818,0.000191113,0.0004580201,0.00001306294,0.0001138023,0.00005655853,2.536712e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000009735451,"about_ca_system_score_gemma":0.0002091556,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000434719,"about_ca_topic_score_gemma":0.000009935938,"domain_scores_codex":[0.9979659,0.000718082,0.0005024114,0.0001848894,0.0004542684,0.0001744215],"domain_scores_gemma":[0.9979704,0.0003590444,0.0007209143,0.0006352494,0.0002351979,0.00007921769],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008503145,0.004952281,0.9289821,0.0001865237,0.001280902,2.840367e-7,0.0006449574,0.001850546,0.001100533,0.0001580566,0.0005517879,0.05178883],"study_design_scores_gemma":[0.003842531,0.001739112,0.9589832,0.001413515,0.0002656838,9.093717e-7,0.0001527193,0.00009437796,0.03322943,0.00006719326,0.00006727778,0.0001439849],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958745,0.002708937,0.00000478849,0.000313358,0.00005587835,0.0008359645,0.000180454,0.000001950815,0.00002411796],"genre_scores_gemma":[0.9987845,0.001004964,0.00001796913,0.00006095287,0.00001809099,0.00004688643,0.00002405366,0.00001708103,0.00002550146],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05164485,"threshold_uncertainty_score":0.284177,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2144174481","doi":"10.1158/2159-8290.cd-14-0341","title":"Targeting Cancer-Derived Adenosine:New Therapeutic Approaches","year":2014,"lang":"en","type":"review","venue":"Cancer Discovery","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":301,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research; American Association for Cancer Research","keywords":"Adenosinergic; Adenosine; Tumor microenvironment; Medicine; Cancer; Adenosine receptor; Disease; Clinical trial; Immune system; Immunotherapy; Cancer research; Immunology; Bioinformatics; Biology; Receptor; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.07511833834698431,"gpt":0.3278120246382449,"spread":0.2526936862912605,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001354657,0.0006272061,0.001168111,0.00006881456,0.0001107562,0.0001195008,0.0005324585,0.0004900015,0.000108033],"category_scores_gemma":[0.00002678647,0.0005043931,0.0005548511,0.0001702296,0.00008131444,0.0000123444,0.0001998811,0.0003187855,0.00001637968],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008861299,"about_ca_system_score_gemma":0.001131757,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001985807,"about_ca_topic_score_gemma":0.00001260693,"domain_scores_codex":[0.9978132,0.0001430116,0.0005248912,0.0008387985,0.0001918595,0.0004882794],"domain_scores_gemma":[0.9988303,0.00003566143,0.0004454614,0.0005137913,0.00003655161,0.0001382299],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004948245,0.00006439388,0.00007654959,0.01160874,0.001674783,0.00000794332,0.00005743083,0.0005696786,0.001478566,0.0001747536,0.1014896,0.8827481],"study_design_scores_gemma":[0.0002234593,0.00005018323,0.000002388186,0.00298303,0.0007648586,0.000007661994,0.00001643843,0.0000114563,0.0004999695,0.00002030166,0.9947448,0.000675481],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005111181,0.9937552,0.00450692,0.00007744477,0.00071236,0.0004453155,0.0001039009,0.00002572342,0.0003219765],"genre_scores_gemma":[0.0004909515,0.9868929,0.00009040524,0.0002749526,0.005660383,0.0003549937,0.0006811249,0.0001509491,0.005403349],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8932551,"threshold_uncertainty_score":0.9997408,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1971817436","doi":"10.1210/me.2003-0021","title":"Deletion of the P2X<sub>7</sub>Nucleotide Receptor Reveals Its Regulatory Roles in Bone Formation and Resorption","year":2003,"lang":"en","type":"article","venue":"Molecular Endocrinology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":290,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Institutes of Health Research; Western University","funders":"Canadian Institutes of Health Research; Mahidol University; Faculty of Science, Mahidol University; Canadian Arthritis Network; Arthritis Society; Pfizer","keywords":"Bone resorption; Osteoclast; Receptor; Internal medicine; Endocrinology; Biology; Resorption; Bone remodeling; Osteoporosis; Bone marrow; Cortical bone; Knockout mouse; Cell biology; Anatomy; Immunology; Medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.006442553166482593,"gpt":0.2083194739827667,"spread":0.2018769208162841,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001597584,0.0001272383,0.0001533578,0.00007928116,0.00004655942,0.000006299707,0.0000917945,0.0001257461,0.000005324129],"category_scores_gemma":[0.000155292,0.0001145892,0.00006221425,0.0001160137,0.00007405944,0.000008514339,0.00007110961,0.0001064714,0.000003428478],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001775974,"about_ca_system_score_gemma":0.00002559723,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004152462,"about_ca_topic_score_gemma":0.000009720776,"domain_scores_codex":[0.9988641,0.0002645203,0.0002932927,0.0002396042,0.0001025322,0.0002359665],"domain_scores_gemma":[0.9994884,0.00001073989,0.0001426541,0.0002622634,0.00006446071,0.00003148848],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0000347531,0.000024694,0.001066184,0.00002344843,0.00001274741,0.000006915122,0.0000306734,0.0002204378,0.9937847,0.003362409,0.0005169723,0.0009160201],"study_design_scores_gemma":[0.0005276144,0.00008678195,0.00323643,0.000027821,0.00001362002,0.0001172597,0.00004394536,0.00002972135,0.9918172,0.000513377,0.003469649,0.0001165868],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9919631,0.006454332,0.0008046955,0.0002035023,0.00007566057,0.0001978316,0.00000396421,0.000007640975,0.0002892312],"genre_scores_gemma":[0.9989219,0.0005530905,0.0001903291,0.0002040758,0.0000292096,0.00002089376,0.00002636285,0.00001644336,0.00003771184],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006958742,"threshold_uncertainty_score":0.467281,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2142045542","doi":"10.1073/pnas.0736323100","title":"Macula densa cell signaling involves ATP release through a maxi anion channel","year":2003,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":286,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; Kidney Foundation of Canada; American Society of Nephrology","keywords":"Macula densa; Tubuloglomerular feedback; Chemistry; Cytosol; Cell biology; Extracellular; Mesangial cell; Epithelial polarity; Membrane potential; Cell; Biophysics; Internal medicine; Endocrinology; Biology; Biochemistry; In vitro; Enzyme; Medicine; Renal function","retraction":null,"screen_n_in":null,"score":{"opus":0.0348285303653109,"gpt":0.2816582913719813,"spread":0.2468297610066704,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005667849,0.0000987521,0.0001026971,0.00004667771,0.0001599698,0.00001540534,0.0003897576,0.0001030967,0.00001007982],"category_scores_gemma":[0.0002416321,0.00007074086,0.00008458803,0.000316551,0.0003014225,0.00002550081,0.00008118081,0.00008983615,7.964192e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000008303824,"about_ca_system_score_gemma":0.00003526579,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004725641,"about_ca_topic_score_gemma":1.277413e-8,"domain_scores_codex":[0.9988747,0.000009104624,0.0002272456,0.0002462155,0.0004918311,0.0001508717],"domain_scores_gemma":[0.9994971,0.00002189684,0.0002657186,0.000009713915,0.0001765922,0.00002893699],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00001266736,0.00003583623,0.0008217805,0.00004338835,0.00001041792,1.1193e-8,0.0001359055,0.0005539709,0.9901237,0.006160863,0.002089399,0.00001207477],"study_design_scores_gemma":[0.0001690813,0.00006102217,0.0003532358,0.00004104038,0.00001083311,0.000009919269,0.0002775864,0.0001519393,0.9839791,0.01265172,0.002200907,0.00009359372],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920805,0.001701581,0.00002018832,0.0004744932,0.00001888942,0.0001025642,0.000006142167,0.000004705191,0.005590976],"genre_scores_gemma":[0.9972178,0.0000998883,0.001787314,0.0004691293,0.0001106339,0.000005567412,6.13269e-7,0.000005751693,0.0003033023],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006490859,"threshold_uncertainty_score":0.2884729,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2083347658","doi":"10.1016/j.tips.2006.06.004","title":"Nucleoside transporters: from scavengers to novel therapeutic targets","year":2006,"lang":"en","type":"review","venue":"Trends in Pharmacological Sciences","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":281,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"Medical Research Council; Canada Research Chairs; Wellcome Trust","keywords":"Nucleoside; Purine; Nucleoside transporter; Biology; Transporter; Adenosine; Biochemistry; Purine metabolism; Gene; Enzyme","retraction":null,"screen_n_in":null,"score":{"opus":0.1101467353773331,"gpt":0.4070846738996914,"spread":0.2969379385223584,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003145376,0.0003741354,0.0007020132,0.0001966968,0.0001038916,0.00004254832,0.0007536762,0.0003029623,0.0007857061],"category_scores_gemma":[0.000009262712,0.0002565578,0.0003121264,0.0007216251,0.0002170794,0.0000057767,0.00009155503,0.0002313689,0.00002457245],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003172041,"about_ca_system_score_gemma":0.00007718546,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008870043,"about_ca_topic_score_gemma":0.00001811202,"domain_scores_codex":[0.9978752,0.0001062887,0.000469048,0.000832664,0.0002374562,0.0004793576],"domain_scores_gemma":[0.99951,0.0000640574,0.0001387442,0.0001386956,0.00001421426,0.0001342767],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003008686,0.0003922068,0.00006010459,0.0001122978,0.0001254922,0.00004610055,0.00003620605,0.0003475966,0.003244318,0.00002863154,0.02238268,0.9731943],"study_design_scores_gemma":[0.000315978,0.0002163308,0.00009644137,0.0002291652,0.0002175447,0.000005470932,0.0000102446,0.00001666819,0.0002870063,0.00002832862,0.9981528,0.0004240394],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001201558,0.9959363,0.0002216542,0.00009697609,0.0002918425,0.0001981496,0.0001081627,0.00002135842,0.001923946],"genre_scores_gemma":[0.01457123,0.9818873,0.001120988,0.0007365721,0.000717446,0.000106186,0.0003776244,0.00002639996,0.0004562845],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9757701,"threshold_uncertainty_score":0.9999887,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2396395844","doi":"10.1016/j.coph.2016.04.001","title":"Immunosuppressive activities of adenosine in cancer","year":2016,"lang":"en","type":"review","venue":"Current Opinion in Pharmacology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":277,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"Cancer Council Victoria; National Health and Medical Research Council","keywords":"Adenosine; Immunosurveillance; Adenosine receptor; Immune system; Purinergic signalling; Purinergic receptor; Immunity; Extracellular; Immunosuppression; Immunology; Biology; Cancer research; Receptor; Medicine; Cell biology; Internal medicine; Agonist","retraction":null,"screen_n_in":null,"score":{"opus":0.0793104981569206,"gpt":0.4529486991460329,"spread":0.3736382009891123,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000129084,0.0003094629,0.0008847333,0.0002761281,0.00001576955,0.000003784099,0.0003328639,0.0003098089,0.000292452],"category_scores_gemma":[0.00001964284,0.0002484235,0.0001985106,0.0001791133,0.0001135009,0.000005243658,0.0002174882,0.0003063795,0.000005327294],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000622408,"about_ca_system_score_gemma":0.0003715921,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000148026,"about_ca_topic_score_gemma":7.504424e-7,"domain_scores_codex":[0.998293,0.0002764945,0.0006277637,0.0004095392,0.00008844028,0.0003047981],"domain_scores_gemma":[0.9992552,0.00008309942,0.0004060477,0.0001791136,0.00003601072,0.00004050172],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001623415,0.0005222795,0.0002635828,0.02171245,0.0003118241,0.000005320266,0.00009464943,0.00003282691,0.0035119,0.00006083403,0.1797991,0.793523],"study_design_scores_gemma":[0.0007918625,0.00007342656,0.000009715773,0.009091348,0.00005764574,0.000008717245,0.000007192403,0.000001517781,0.0014858,0.00000875778,0.9882032,0.0002607812],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003421445,0.9933868,0.00002018834,0.00002944914,0.005570028,0.0004318535,0.0001601575,0.000004317314,0.00005507183],"genre_scores_gemma":[0.0005190865,0.9972771,0.000006228674,0.000008854112,0.001415244,0.0004138277,0.0002287567,0.00003409201,0.00009674524],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8084042,"threshold_uncertainty_score":0.9999968,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2917112529","doi":"10.1161/circulationaha.118.037418","title":"Evaluation of Glomerular Hemodynamic Function by Empagliflozin in Diabetic Mice Using In Vivo Imaging","year":2019,"lang":"en","type":"article","venue":"Circulation","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":276,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network","funders":"Canadian Institutes of Health Research; Kawasaki Medical School","keywords":"Tubuloglomerular feedback; Endocrinology; Internal medicine; Medicine; Empagliflozin; Renal function; Glomerular hyperfiltration; Kidney; Diabetes mellitus; Diabetic nephropathy; Type 2 diabetes","retraction":null,"screen_n_in":null,"score":{"opus":0.01088100229485375,"gpt":0.2549299437366544,"spread":0.2440489414418006,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005834641,0.00007700586,0.00009655102,0.00009827656,0.00001201057,0.000006308889,0.00004272132,0.00006918284,0.00004189774],"category_scores_gemma":[0.00003820004,0.0000911327,0.00003007979,0.0001700589,0.00001130116,0.00001206707,0.00001587439,0.00004408053,0.000002272703],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007524188,"about_ca_system_score_gemma":0.0000555373,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001111027,"about_ca_topic_score_gemma":0.00001064981,"domain_scores_codex":[0.9991474,0.0001129071,0.0002140304,0.0002051528,0.0002059135,0.0001146492],"domain_scores_gemma":[0.9996582,0.000007278398,0.00009058337,0.0001318554,0.00009777769,0.00001426502],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.00001096532,0.0000200896,0.2232586,0.00001352869,0.000005724891,1.206456e-7,0.00002809756,0.06796966,0.7080968,0.00000438041,0.00001914533,0.0005729177],"study_design_scores_gemma":[0.001554588,0.00002518992,0.1569124,0.00007730711,0.00006587157,0.000003191027,0.0001331447,0.728406,0.1122378,0.0003263975,0.00006316588,0.0001949823],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9937871,0.002316103,0.003354585,0.00001112304,0.00009353885,0.000226274,0.000002833161,0.000003202279,0.0002052705],"genre_scores_gemma":[0.9997688,0.000006993407,0.0000554423,0.0000247459,0.00003628472,0.000005949245,0.000082495,0.00001160459,0.000007695015],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6604363,"threshold_uncertainty_score":0.3716283,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3173777885","doi":"10.1038/s41591-021-01390-x","title":"Self-tunable engineered yeast probiotics for the treatment of inflammatory bowel disease","year":2021,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":274,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Concordia University; University of Toronto","funders":"","keywords":"Purinergic receptor; Apyrase; Inflammatory bowel disease; Inflammation; Immunology; Dysbiosis; Purinergic signalling; Gastrointestinal tract; Medicine; Immune system; Microbiology; Biology; Receptor; Gut flora; Disease; Internal medicine; Adenosine receptor","retraction":null,"screen_n_in":null,"score":{"opus":0.005103320351037654,"gpt":0.2392433507926461,"spread":0.2341400304416085,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006336867,0.0001056842,0.0001148495,0.00001621504,0.0000409298,0.000002892689,0.00007941563,0.0001310693,0.00001900387],"category_scores_gemma":[0.0001111594,0.00006293908,0.0000722241,0.0000581263,0.00003718457,0.00000112492,0.00001514277,0.00006645448,4.853497e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001143837,"about_ca_system_score_gemma":0.0001108958,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000125739,"about_ca_topic_score_gemma":0.000001840328,"domain_scores_codex":[0.9994786,0.0000139442,0.0001326202,0.0001563896,0.00009608436,0.0001223049],"domain_scores_gemma":[0.9994411,0.00003462133,0.00004615158,0.0002653721,0.000149708,0.0000629792],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001292733,0.001268532,0.005756346,0.001299462,0.001727608,0.0001410321,0.001221,0.002195777,0.8281119,0.003703428,0.1502391,0.003043107],"study_design_scores_gemma":[0.002037655,0.0006477017,0.001384991,0.00005287777,0.0002906911,0.00001133002,0.0001647503,0.0007049107,0.3165978,0.00006395087,0.6779148,0.0001285301],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6582934,0.3276093,0.004702589,0.006231433,0.001150867,0.001131439,0.0001131987,0.00004260599,0.0007251185],"genre_scores_gemma":[0.993287,0.00204266,0.0007839122,0.0002934672,0.001398448,0.00003176372,0.0002423755,0.00001817691,0.001902256],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5276757,"threshold_uncertainty_score":0.2566581,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2069219003","doi":"10.1097/01.jnen.0000240470.97295.d3","title":"Upregulated Expression of Purinergic P2X<sub>7</sub>Receptor in Alzheimer Disease and Amyloid-β Peptide-Treated Microglia and in Peptide-Injected Rat Hippocampus","year":2006,"lang":"en","type":"article","venue":"Journal of Neuropathology & Experimental Neurology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":274,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"National Institute on Aging","keywords":"Microglia; Purinergic receptor; Hippocampus; Downregulation and upregulation; Peptide; Alzheimer's disease; Amyloid (mycology); Receptor; Chemistry; P3 peptide; Neuroscience; Amyloid β; Amyloid precursor protein; Endocrinology; Internal medicine; Cell biology; Biology; Disease; Medicine; Biochemistry; Inflammation; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.005928114466319196,"gpt":0.2258221981121669,"spread":0.2198940836458477,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002167561,0.0003042883,0.0004871356,0.0003032676,0.0000432298,0.00001163989,0.0001652682,0.0002282707,0.000008301113],"category_scores_gemma":[0.00004964785,0.0002852171,0.00009606837,0.0001598965,0.0003175919,0.00002289302,0.0002019521,0.0003294075,8.3841e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000009302946,"about_ca_system_score_gemma":0.00004344241,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000174055,"about_ca_topic_score_gemma":0.00000813756,"domain_scores_codex":[0.9977465,0.000483625,0.0008182437,0.0004637741,0.0001231244,0.0003646942],"domain_scores_gemma":[0.9990717,0.00005957198,0.0004490308,0.0002002632,0.00007307809,0.000146319],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002877052,0.0003462406,0.08014941,0.000009472514,0.00001396363,0.00141433,0.00005256328,0.0003210675,0.9141345,0.000002137057,0.0006046284,0.00007462612],"study_design_scores_gemma":[0.002394595,0.001347121,0.1044585,0.00003003234,0.00003753394,0.001434384,0.00002756224,0.00003262375,0.8898835,0.00003614769,0.0001285233,0.0001894584],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9864709,0.01295291,0.000006920882,0.0001445982,0.0001992129,0.0001912421,0.000007213412,0.000007436742,0.00001955249],"genre_scores_gemma":[0.9990241,0.0003964872,0.00008481619,0.0002521152,0.0001539691,0.000007600605,0.00002686258,0.00004141037,0.00001265238],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02430912,"threshold_uncertainty_score":0.99996,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2023648193","doi":"10.1007/s00439-002-0798-z","title":"Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency","year":2002,"lang":"en","type":"article","venue":"Human Genetics","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":268,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Thomas Hospital","funders":"Daiwa Anglo-Japanese Foundation","keywords":"ITPA; Biology; Inosine monophosphate; Heterozygote advantage; Compound heterozygosity; Mutation; Allele; Genetics; Biochemistry; Genotype; Nucleotide; Molecular biology; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.01800917140169264,"gpt":0.2342233711002508,"spread":0.2162141996985582,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007467432,0.0002032521,0.0001959395,0.00006733221,0.0001057035,0.00001645297,0.0002957673,0.000139827,0.0004896242],"category_scores_gemma":[0.0000238808,0.0002068328,0.0001227492,0.0001757682,0.0001242213,0.000002097332,0.0001169582,0.00007665307,0.00003003549],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00000856456,"about_ca_system_score_gemma":0.00001867037,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001924806,"about_ca_topic_score_gemma":0.000003156577,"domain_scores_codex":[0.9987224,0.00003636296,0.0003928574,0.0003490128,0.0001976659,0.0003016606],"domain_scores_gemma":[0.9991371,0.000008237452,0.0001476156,0.0005005223,0.0001034279,0.0001030701],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00003044703,0.0003368332,0.01241694,0.00006421318,0.00005588053,0.00002123642,0.0001586036,0.0023224,0.9560328,0.000130774,0.02511858,0.003311339],"study_design_scores_gemma":[0.001217023,0.000900399,0.01018951,0.00002304341,0.00008749933,0.00003219693,0.00003348506,0.001281329,0.9668972,0.0001296388,0.01873985,0.0004688392],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9602976,0.03652003,0.0009575452,0.00002462387,0.00009745217,0.0001341516,0.00001396758,0.00001443924,0.001940122],"genre_scores_gemma":[0.9953633,0.001402255,0.001443114,0.0001352177,0.000213194,0.000009992892,0.00002323498,0.00003855225,0.001371116],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03511777,"threshold_uncertainty_score":0.8434399,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1947060780","doi":"10.1158/0008-5472.can-14-3569","title":"CD73 Is Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":260,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Université de Montréal; Centre Hospitalier de l’Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Ovarian cancer; Cancer research; Stromal cell; Metastasis; Serous fluid; Biology; Cancer; Tumor progression; Medicine; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.07876753002403131,"gpt":0.372916400839012,"spread":0.2941488708149806,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005478907,0.0001313442,0.0001618063,0.00009769935,0.00007264491,0.00004067039,0.0002500518,0.0001623467,0.0001233343],"category_scores_gemma":[0.00008113038,0.0001094228,0.00002837032,0.0005012663,0.0001030016,0.000006368341,0.0001164513,0.0002822331,0.000008053883],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001611193,"about_ca_system_score_gemma":0.0007199589,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00662441,"about_ca_topic_score_gemma":0.001735571,"domain_scores_codex":[0.9983386,0.0001641439,0.0001471822,0.0003964969,0.0004346471,0.0005189509],"domain_scores_gemma":[0.9992111,0.00002141871,0.00004319483,0.0001831405,0.0003674082,0.0001737157],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001247728,0.0005419216,0.307618,0.00008370016,0.0006544616,0.0002681981,0.001365047,0.001645539,0.2572073,0.0001492304,0.426395,0.002823893],"study_design_scores_gemma":[0.007009754,0.001472492,0.02230624,0.0004330905,0.00006121962,0.00001949847,0.0007117771,0.0002082251,0.9124506,0.0003270969,0.05418148,0.0008185414],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917088,0.005019614,0.00002154934,0.002428856,0.00007501392,0.0002862862,0.00004778513,0.0000122848,0.0003998306],"genre_scores_gemma":[0.9957219,0.000320176,0.00006381978,0.0003199879,0.0003857216,0.0003879232,0.00005659563,0.00003522223,0.002708595],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6552433,"threshold_uncertainty_score":0.9999906,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2172099127","doi":"10.1093/hmg/ddl166","title":"P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder","year":2006,"lang":"en","type":"article","venue":"Human Molecular Genetics","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":255,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Wilfrid Laurier University; Université Laval","funders":"Bundesministerium für Bildung und Forschung","keywords":"Single-nucleotide polymorphism; Biology; Genetics; Purinergic receptor; Locus (genetics); Major depressive disorder; Gene; SNP; Coding region; Allele; Population; Genotype; Receptor; Endocrinology; Medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.009287419875598002,"gpt":0.2353512518364564,"spread":0.2260638319608584,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001047717,0.0003621454,0.000278823,0.00008578607,0.0002900706,0.00007006419,0.0002564215,0.0002639862,0.00001638881],"category_scores_gemma":[0.00002825279,0.0003473308,0.0001630926,0.0001727889,0.00008699671,0.000004330292,0.0001139207,0.0001099119,0.000003207982],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002173931,"about_ca_system_score_gemma":0.0000594051,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005942738,"about_ca_topic_score_gemma":0.00004648673,"domain_scores_codex":[0.9982395,0.000055233,0.0003386626,0.0006096534,0.0002409723,0.0005160141],"domain_scores_gemma":[0.9989911,0.00001437733,0.0002166615,0.0004172325,0.0002614882,0.00009909012],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00007345557,0.0001748067,0.001411872,0.0000285751,0.0002443309,0.00005380992,0.00004948946,0.005621722,0.9869845,0.0001430401,0.005172587,0.00004181605],"study_design_scores_gemma":[0.003304495,0.0006853841,0.001704977,0.00005751423,0.0002258512,0.00003503155,0.00003318299,0.0009753078,0.9877731,0.0005608308,0.004008234,0.0006361423],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9571514,0.006140287,0.03565116,0.00008762982,0.00005664327,0.0005361768,0.00006756112,0.00004044488,0.0002686682],"genre_scores_gemma":[0.9959353,0.00007261323,0.0008201953,0.0003632562,0.0003476846,0.0001002699,0.001240607,0.0001119896,0.001008128],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03878383,"threshold_uncertainty_score":0.9998979,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2016675737","doi":"10.1016/s0736-5748(00)00084-8","title":"Involvement of astrocytes in purine‐mediated reparative processes in the brain","year":2001,"lang":"en","type":"review","venue":"International Journal of Developmental Neuroscience","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":243,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"","keywords":"Purine metabolism; Astrocyte; Adenosine; Guanosine; Purinergic receptor; Biology; Purinergic signalling; Biochemistry; Purine nucleoside phosphorylase; Purine; Receptor; Adenosine deaminase; Cell biology; Adenosine receptor; Neuroscience; Central nervous system; Enzyme","retraction":null,"screen_n_in":null,"score":{"opus":0.04489108597455716,"gpt":0.3409970884865003,"spread":0.2961060025119432,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000457196,0.0001576242,0.000324094,0.0002620378,0.00001731511,0.00002841167,0.0009536916,0.00006154384,0.000006108238],"category_scores_gemma":[0.0006540027,0.0001052324,0.00009032285,0.0004595726,0.00009134357,0.00001693384,0.0001360174,0.0001915002,7.62894e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005597856,"about_ca_system_score_gemma":0.0008124639,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006693918,"about_ca_topic_score_gemma":0.00001591985,"domain_scores_codex":[0.9983296,0.0001090262,0.0007636441,0.0001943522,0.0004725922,0.000130735],"domain_scores_gemma":[0.9990004,0.0001059142,0.0006343312,0.0000656788,0.0001658785,0.00002774412],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002398466,0.01107382,0.06533456,0.01426215,0.001521464,0.01295065,0.01472612,0.00273073,0.103869,0.0004842471,0.06577087,0.704878],"study_design_scores_gemma":[0.0005183608,0.000276599,0.0005149491,0.00299124,0.0000151113,0.001213017,0.0002503934,0.000003489723,0.003024915,0.00001373325,0.9909801,0.000198087],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.03353668,0.96505,0.0001159275,0.0002023675,0.0005192134,0.0002836546,0.00001821872,0.000001471967,0.0002724587],"genre_scores_gemma":[0.0269755,0.972107,0.0002875423,0.0003440859,0.0001317302,0.0000139528,0.00003333644,0.00000984664,0.00009701632],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9252092,"threshold_uncertainty_score":0.4291254,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2769890142","doi":"10.1093/annonc/mdx730","title":"Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":240,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Breast cancer; Clinical trial; Oncology; Clinical significance; Triple-negative breast cancer; Multiplex; Phases of clinical research; Internal medicine; Cancer; Bioinformatics","retraction":null,"screen_n_in":null,"score":{"opus":0.1791694009176477,"gpt":0.5192750189657375,"spread":0.3401056180480898,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001760362,0.0001462861,0.001250398,0.0001403663,0.000041725,0.000004051908,0.0004810792,0.0004040877,0.00008380445],"category_scores_gemma":[0.00125331,0.000133683,0.0006264448,0.0001871594,0.0007008769,0.000007915536,0.000150035,0.0001851101,4.893864e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000006612687,"about_ca_system_score_gemma":0.0004577079,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001568294,"about_ca_topic_score_gemma":0.0006301649,"domain_scores_codex":[0.9971507,0.0004494777,0.001630771,0.0004072923,0.000136039,0.0002257892],"domain_scores_gemma":[0.9967066,0.0003944227,0.001805276,0.0006023811,0.0003955495,0.00009574454],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2814348,0.01333768,0.3798035,0.0001013433,0.009284429,0.00006053474,0.0004342593,0.0009450957,0.07907225,0.0001787165,0.01608597,0.2192614],"study_design_scores_gemma":[0.3429034,0.03277824,0.4618112,0.0001578956,0.002556504,0.000008484959,0.0004971629,0.003487213,0.1405481,0.0002749269,0.01409246,0.0008844779],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973273,0.0005174928,0.0001510436,0.000563073,0.0002833711,0.0003402279,0.0002611155,0.000002085916,0.0005542641],"genre_scores_gemma":[0.9970427,0.001899095,0.0002750424,0.0001776537,0.0004146023,0.00002871628,0.00004084473,0.000009793839,0.0001115224],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2183769,"threshold_uncertainty_score":0.5451433,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2058026592","doi":"10.1158/0008-5472.can-14-0957","title":"Antimetastatic Effects of Blocking PD-1 and the Adenosine A2A Receptor","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":239,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Blocking (statistics); Chemistry; Adenosine A2A receptor; Adenosine; Receptor; Adenosine receptor; Pharmacology; Medicine; Agonist; Biochemistry; Computer science","retraction":null,"screen_n_in":null,"score":{"opus":0.01740714486105991,"gpt":0.3366179294889171,"spread":0.3192107846278572,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007923328,0.000069938,0.0001286916,0.00004054357,0.0001007531,0.00001729623,0.0001596055,0.00004712729,0.00003310738],"category_scores_gemma":[0.0003018577,0.00004615085,0.00003382529,0.0001307698,0.0003112872,0.000001918376,0.0001337267,0.000128222,0.000003480849],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000005739762,"about_ca_system_score_gemma":0.00004801929,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001242321,"about_ca_topic_score_gemma":0.000003182789,"domain_scores_codex":[0.9990231,0.0002818842,0.0001129499,0.0001836096,0.0001915773,0.0002068449],"domain_scores_gemma":[0.9993487,0.0002299366,0.00003741547,0.0002113782,0.0001258368,0.00004673214],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002740088,0.00002289267,0.0009580469,0.000232722,0.00009651715,0.000001154965,0.0001776132,0.000047202,0.975932,0.0008557579,0.01750205,0.003900057],"study_design_scores_gemma":[0.001752444,0.0002463617,0.0004957278,0.000114528,0.00002702774,0.000003764191,0.00004994162,0.0001564568,0.9690286,0.0002600832,0.02776773,0.00009736828],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9806442,0.01748561,0.0005592164,0.0006459555,0.000070496,0.0002101664,0.000002748241,0.000003346393,0.0003782566],"genre_scores_gemma":[0.9973778,0.001261201,0.0001334346,0.00009595618,0.0003177079,0.00004482039,0.000006327304,0.00001324401,0.0007495469],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01673356,"threshold_uncertainty_score":0.1881977,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2326948553","doi":"10.3899/jrheum.110874","title":"Efficacy and Safety of CE-224,535, an Antagonist of P2X<sub>7</sub>Receptor, in Treatment of Patients with Rheumatoid Arthritis Inadequately Controlled by Methotrexate","year":2012,"lang":"en","type":"article","venue":"The Journal of Rheumatology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":238,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false},"ca_institutions":"","funders":"Pfizer","keywords":"Medicine; Placebo; Rheumatoid arthritis; Internal medicine; Adverse effect; Rheumatology; Methotrexate; Clinical endpoint; Nausea; Arthritis; Gastroenterology; Randomized controlled trial; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.007212974894057878,"gpt":0.2303127607684511,"spread":0.2230997858743933,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000512884,0.0001784571,0.0008298255,0.00008618189,0.00003767273,0.000003029624,0.0001465929,0.0001192981,0.00001010115],"category_scores_gemma":[0.00007872684,0.0001113252,0.000082813,0.00008718699,0.0002413999,0.00001568423,0.00003376812,0.00008654023,2.947932e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001349458,"about_ca_system_score_gemma":0.00007449757,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001198285,"about_ca_topic_score_gemma":0.00001973782,"domain_scores_codex":[0.9982538,0.0004219156,0.0008454011,0.0001057295,0.0001465032,0.0002266106],"domain_scores_gemma":[0.9983359,0.0001833144,0.001037872,0.0001877696,0.0001654219,0.00008971228],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.02437519,0.001944803,0.5009936,0.00006416316,0.0008252267,0.000001908403,0.001555709,0.0001457191,0.4612853,0.0001145837,0.000344524,0.008349264],"study_design_scores_gemma":[0.05130814,0.008745496,0.04661903,0.0003542934,0.0001705375,0.0005131364,0.0006465588,0.00003224907,0.8902844,0.00004434716,0.0009392281,0.0003425664],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9855072,0.01382856,0.0002790229,0.00005051267,0.00006666031,0.0002151745,0.00003195433,0.000001331931,0.0000195596],"genre_scores_gemma":[0.9809456,0.0187656,0.0002202805,0.000009328173,0.000007742951,0.000002818556,0.00002956739,0.00001633502,0.000002759757],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4543746,"threshold_uncertainty_score":0.4539709,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2108067308","doi":"10.1161/01.res.0000144796.82787.6f","title":"Targeted Disruption of <i>cd73</i> /Ecto-5′-Nucleotidase Alters Thromboregulation and Augments Vascular Inflammatory Response","year":2004,"lang":"en","type":"article","venue":"Circulation Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":235,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Canadian Institutes of Health Research; Deutsche Gesellschaft für Kardiologie-Herz und Kreislaufforschung.; Deutsche Forschungsgemeinschaft","keywords":"In vivo; Intravital microscopy; 5'-nucleotidase; Ex vivo; Western blot; Chemistry; Adenosine; Internal medicine; Endocrinology; Endothelium; Platelet; Biology; Medicine; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.02604944779979335,"gpt":0.3208412124139158,"spread":0.2947917646141225,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001089723,0.00009864831,0.0001068707,0.0001542877,0.0001426304,0.00002517859,0.00009020703,0.000121833,0.00002145265],"category_scores_gemma":[0.0001729533,0.0001022173,0.00005437698,0.0002161335,0.0001556113,0.0000177231,0.00007677097,0.0001032411,0.000005945745],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004044114,"about_ca_system_score_gemma":0.0001086728,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005892762,"about_ca_topic_score_gemma":0.000003974779,"domain_scores_codex":[0.9986057,0.0002784676,0.0002325785,0.0002894498,0.0003814856,0.0002123791],"domain_scores_gemma":[0.99928,0.00003669499,0.00007136864,0.0002830598,0.00024515,0.0000836845],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0002962092,0.0000481123,0.02346576,0.0000418025,0.00005237646,0.00000304656,0.0001927402,0.01772783,0.9575219,0.0001949646,0.000142888,0.0003123698],"study_design_scores_gemma":[0.001879253,0.0002433134,0.793334,0.00006832518,0.00001855982,0.000008303148,0.0001770904,0.000905751,0.2017109,0.0008623075,0.0005842995,0.000207869],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955418,0.000924451,0.003009308,0.0001360469,0.00003606983,0.000275174,0.000005831937,0.00001120845,0.0000601139],"genre_scores_gemma":[0.9994125,0.00007680309,0.0001990039,0.00002681241,0.0000928814,0.00001547277,0.000126298,0.00001881491,0.00003142786],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7698683,"threshold_uncertainty_score":0.4168301,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1528781834","doi":"10.1523/jneurosci.21-18-07135.2001","title":"P2X7-Like Receptor Activation in Astrocytes Increases Chemokine Monocyte Chemoattractant Protein-1 Expression via Mitogen-Activated Protein Kinase","year":2001,"lang":"en","type":"article","venue":"Journal of Neuroscience","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":233,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research; National Institutes of Health; National Institute of Neurological Disorders and Stroke; Fondation pour la Recherche Médicale","keywords":"Purinergic receptor; P2 receptor; Downregulation and upregulation; Purinergic signalling; Cell biology; Receptor; Astrocyte; PPADS; Chemokine receptor; p38 mitogen-activated protein kinases; Signal transduction; Biology; Chemokine; MAPK/ERK pathway; Chemistry; Endocrinology; Agonist; Extracellular; Biochemistry; Adenosine receptor","retraction":null,"screen_n_in":null,"score":{"opus":0.01703000374445852,"gpt":0.2537180672215215,"spread":0.2366880634770629,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002552475,0.0001802329,0.0001936456,0.0001309129,0.00008854795,0.00004158809,0.0003096602,0.00009902791,0.00001376519],"category_scores_gemma":[0.000381066,0.0001497764,0.00008040132,0.0003426386,0.00007257767,0.00006018215,0.00008636145,0.0002367098,0.000001033528],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000412578,"about_ca_system_score_gemma":0.0001363308,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002082352,"about_ca_topic_score_gemma":7.749619e-7,"domain_scores_codex":[0.9985962,0.0000874219,0.000423679,0.0002934482,0.0003282319,0.0002710502],"domain_scores_gemma":[0.9990466,0.0000142173,0.0004660527,0.0001909893,0.0001511373,0.0001310529],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0006539595,0.0001992142,0.0006531397,0.00001040848,0.000002762647,0.00002493424,0.00002294054,0.0001590281,0.9974468,7.017798e-7,0.0002690386,0.0005571127],"study_design_scores_gemma":[0.0008018911,0.0005384933,0.002141544,0.0001563467,0.000003841998,0.00009493326,0.00002916032,0.00008802113,0.9895179,0.000008526991,0.006462316,0.0001570355],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962839,0.0001875483,0.002932877,0.0001823888,0.0001397231,0.0002407318,0.000001460414,0.000007239896,0.00002406942],"genre_scores_gemma":[0.9980386,0.00005935114,0.00102521,0.0001617455,0.0003673392,0.00001416742,0.000005152123,0.00001815666,0.0003102896],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007928869,"threshold_uncertainty_score":0.6107703,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2070851085","doi":"10.1007/s10555-007-9044-4","title":"The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs","year":2007,"lang":"en","type":"review","venue":"Cancer and Metastasis Reviews","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":230,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Nucleoside; Nucleoside analogue; Nucleoside transporter; Transporter; Pharmacology; Drug resistance; Biology; Chemistry; Biochemistry; Gene; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.03386769529784486,"gpt":0.3504689118339231,"spread":0.3166012165360783,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004681371,0.0004053764,0.001316859,0.00006682699,0.00005654647,0.00001685764,0.0002569894,0.0001643097,0.00002797887],"category_scores_gemma":[0.00000603626,0.0002293884,0.0003340877,0.0002572278,0.0001359064,0.000004480289,0.00002214476,0.0001939014,7.694309e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002846987,"about_ca_system_score_gemma":0.0001736046,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001364823,"about_ca_topic_score_gemma":0.0001954554,"domain_scores_codex":[0.9983644,0.00009113663,0.000728062,0.0003876545,0.000125104,0.0003036501],"domain_scores_gemma":[0.9991225,0.00002954337,0.0003576975,0.000366087,0.00003860835,0.00008556355],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002776346,0.00001444416,0.00003429261,0.002578703,0.0002177302,0.000001403897,0.00005998966,0.000003084211,0.00008736024,0.000007215083,0.001316463,0.9956515],"study_design_scores_gemma":[0.000258881,0.00004964071,0.000004844504,0.004147629,0.0005235736,0.000005650189,0.00006098225,8.128048e-7,0.0009949446,0.000003640123,0.9936726,0.0002767852],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005122923,0.9982533,0.00003075437,0.00002108921,0.00007159835,0.0007557008,0.00006995644,0.000004155584,0.0002811507],"genre_scores_gemma":[0.0001473494,0.9987605,0.0001109099,0.0001575084,0.0002204363,0.0003304811,0.00004507768,0.00006196152,0.000165802],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9953747,"threshold_uncertainty_score":0.9354188,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2071777696","doi":"10.1038/ncomms4771","title":"Transcription factor IRF5 drives P2X4R+-reactive microglia gating neuropathic pain","year":2014,"lang":"en","type":"article","venue":"Nature Communications","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":223,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Core Research for Evolutional Science and Technology; Japan Science and Technology Agency; Japan Society for the Promotion of Science; Council for Science and Technology Policy; Ministry of Education, Culture, Sports, Science and Technology","keywords":"IRF8; Microglia; IRF5; Neuropathic pain; Interferon regulatory factors; Transcription factor; Medicine; Immunology; Cancer research; Neuroscience; Biology; Gene; Inflammation; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.01377347910485571,"gpt":0.2694283080793868,"spread":0.2556548289745311,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004752945,0.0001308183,0.000103354,0.0000387795,0.0002400358,0.00002817776,0.0005476828,0.0002674517,0.00001096546],"category_scores_gemma":[0.000591884,0.0001278674,0.00008710286,0.0001007534,0.00008141316,0.000007021058,0.0001141269,0.0005341403,0.000008331955],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000009912686,"about_ca_system_score_gemma":0.00002830262,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001279131,"about_ca_topic_score_gemma":0.00003749121,"domain_scores_codex":[0.9986873,0.0006963242,0.0001672398,0.0002116576,0.00008519063,0.0001523178],"domain_scores_gemma":[0.9986475,0.0001666959,0.00009103569,0.000923208,0.0001184759,0.00005308877],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001103396,0.0000605438,0.002065259,0.000007679275,0.00002642576,2.620333e-7,0.0002298657,0.00001714148,0.9883851,0.0008650061,0.003042922,0.005288721],"study_design_scores_gemma":[0.0007098638,0.0002978989,0.01216836,0.00007647971,0.00007129616,0.00002394534,0.0003581764,0.003935811,0.2737494,0.0003742246,0.7076113,0.0006233012],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9105324,0.03032702,0.04477156,0.005857672,0.0004038624,0.0004981816,0.00007560732,0.0001389346,0.007394772],"genre_scores_gemma":[0.9946529,0.0002903624,0.003218214,0.001111635,0.000202961,0.00002011231,0.0002850001,0.00002273736,0.0001961223],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7146357,"threshold_uncertainty_score":0.521428,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2608512240","doi":"10.3390/molecules22040676","title":"Adenosine A1 and A2A Receptors in the Brain: Current Research and Their Role in Neurodegeneration","year":2017,"lang":"en","type":"review","venue":"Molecules","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":220,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Saskatchewan","funders":"Canada Foundation for Innovation","keywords":"Neuroprotection; Neurodegeneration; Neurotoxicity; Adenosine A2A receptor; Neuroscience; Adenosine; Inhibitory postsynaptic potential; Adenosine receptor; Receptor; Excitatory postsynaptic potential; Pharmacology; Biology; Medicine; Disease; Agonist; Internal medicine; Toxicity","retraction":null,"screen_n_in":null,"score":{"opus":0.1301617751409836,"gpt":0.4023701332544821,"spread":0.2722083581134985,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007118253,0.0002459452,0.0003971694,0.0001554381,0.00013261,0.0001195467,0.0003294995,0.0002117301,0.00000280484],"category_scores_gemma":[0.0001878957,0.0001601506,0.00006174039,0.0001228379,0.0001374015,0.000004735928,0.0002291189,0.0004256736,0.000001829405],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001166819,"about_ca_system_score_gemma":0.00009533799,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004035082,"about_ca_topic_score_gemma":0.00005687492,"domain_scores_codex":[0.998374,0.0004880658,0.0002778386,0.0004747767,0.0001274835,0.0002578511],"domain_scores_gemma":[0.9993163,0.00008535514,0.0001029334,0.0004142196,0.00003960665,0.00004155792],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001352231,0.00007115165,0.00009319145,0.0009945735,0.00001906661,0.0000137053,0.0002187545,0.000003421432,0.0004381705,0.0001491513,0.006116813,0.9918685],"study_design_scores_gemma":[0.0001558597,0.0001166809,0.00004517405,0.0009354233,0.00001205321,0.0000312133,0.00005230119,0.00001290955,0.0001850408,0.00009561405,0.9981811,0.0001766548],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.007059283,0.9919421,0.00001955888,0.0002824089,0.00007411498,0.0004099795,0.00001265743,0.000002730551,0.0001971537],"genre_scores_gemma":[0.00563125,0.9934949,0.00001734847,0.00005230321,0.0003140137,0.00009702921,0.0002244382,0.00002879601,0.0001399],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9920642,"threshold_uncertainty_score":0.653075,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2129051737","doi":"10.1158/1078-0432.ccr-08-2080","title":"Human Equilibrative Nucleoside Transporter 1 and Human Concentrative Nucleoside Transporter 3 Predict Survival after Adjuvant Gemcitabine Therapy in Resected Pancreatic Adenocarcinoma","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":218,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Gemcitabine; Medicine; Oncology; Adenocarcinoma; Nucleoside transporter; Internal medicine; Adjuvant therapy; Deoxycytidine; Nucleoside analogue; Chemoradiotherapy; Radiation therapy; Gastroenterology; Chemotherapy; Nucleoside; Cancer; Transporter; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.0951877190489821,"gpt":0.4358335750077502,"spread":0.3406458559587681,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00126936,0.0003206574,0.0005863979,0.0001213826,0.0001814117,0.00005943572,0.00035429,0.0003628418,0.0005559563],"category_scores_gemma":[0.00005259376,0.0002708304,0.0001744108,0.0002993384,0.0006713392,0.00002936394,0.00005412992,0.0008555543,0.000003144118],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004107191,"about_ca_system_score_gemma":0.000196537,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003706881,"about_ca_topic_score_gemma":0.0006496273,"domain_scores_codex":[0.9961863,0.0007066144,0.0008844282,0.000950217,0.0004991259,0.000773365],"domain_scores_gemma":[0.9987361,0.0001340867,0.0001050303,0.0004692073,0.0002446388,0.00031088],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004152654,0.0006229112,0.7791362,0.00004807841,0.000268611,0.0003343257,0.001143399,0.00001812024,0.2101199,0.0003378855,0.002189056,0.001628787],"study_design_scores_gemma":[0.004492396,0.003688403,0.9772033,0.0001672916,0.00003709229,0.0000039714,0.0002373885,0.00003113548,0.0120245,0.0006838163,0.001065071,0.0003656117],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9894924,0.007820283,0.00004468537,0.0008302584,0.00006522501,0.0007430523,0.00007409837,0.00002247361,0.0009075821],"genre_scores_gemma":[0.9966848,0.001392186,0.00005593106,0.0005077872,0.0006416264,0.0001404463,0.000125547,0.00004637136,0.0004052556],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1980954,"threshold_uncertainty_score":0.9999744,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}